rfhg_152417.1

Basic information about the TSS

---

TSS ID: rfhg_152417.1 Species: human Chr: chr12		Start: 57520699 End: 57520726 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2564833,EH38E1616652)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000548887.5:0 GeneID: 114785 HGNC/MGI_ID: HGNC:20445 UniProt_ID: F8VU14 Nearer transcript ids and distances: LF324160:-222 MA559737:-222 ENST00000551351.5:239 ENST00000549231.5:322 LF324163:-342 MA559740:-342 view more...

Gene_name: methyl-CpG binding domain protein 6 Gene_symbol: MBD6 Gene_synonyms: KIAA1887 Gene_source: HGNC:20445

TATA-Box annotation

---

Distance to TSS:	-195
Nearest PromoterID:	NM_001195054
Entrez ID:	1649
Nearest Unigene:	Hs.505777
Nearest Refseq:	NM_004083
Nearest Ensembl:	ENSG00000175197
Gene Name:	methyl-CpG binding domain protein 6
Gene Alias:	AltDDIT3|C/EBPzeta|CEBPZ|CHOP|CHOP-10|CHOP10|GADD153
Gene Type:	protein-coding
CpG%:	0.074074
GC%:	0.642857
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@MBD6 p2@MBD6 p3@MBD6 p4@MBD6 p5@MBD6 p6@MBD6 p7@MBD6
Sample		p1@MBD6	p2@MBD6	p3@MBD6	p4@MBD6	p5@MBD6	p6@MBD6	p7@MBD6
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	25.13	3.31	2.53	2.34	0.39	0.19	1.36
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	22.05	3.24	1.62	1.42	0.61	0.81	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	21.99	3.28	2.31	3.28	0.58	0.77	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	20.58	0.83	1.25	0.83	0.42	0.21	1.04
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	20.02	2.47	1.80	1.35	0.00	0.00	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	17.64	0.97	1.16	1.55	0.39	0.58	0.97
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	26.58	1.96	3.05	1.96	0.00	1.31	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	19.86	1.94	3.63	2.66	0.24	0.24	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	23.72	2.78	2.78	1.50	0.21	0.43	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	23.19	2.32	3.48	4.06	1.74	0.00	1.74
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	16.17	3.64	1.62	4.04	0.00	0.40	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	19.92	0.81	1.63	1.22	0.00	0.00	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	13.54	6.29	2.10	1.61	0.00	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	13.83	6.62	1.35	1.20	0.00	0.30	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	13.17	5.71	1.76	0.44	0.00	0.66	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	16.60	4.78	2.26	1.76	0.00	1.01	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	11.36	3.06	1.75	0.44	0.00	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	8.86	4.22	1.27	1.69	0.00	0.84	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	9.60	6.93	2.67	1.60	0.00	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	11.73	6.02	1.65	1.20	0.00	0.15	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	13.10	4.81	1.74	1.47	0.13	0.27	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	14.16	6.21	3.11	1.90	0.00	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	12.28	3.75	1.81	0.78	0.00	0.39	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	14.56	4.13	1.94	1.70	0.00	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	11.61	6.19	2.32	0.00	0.00	1.03	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	12.66	4.43	2.53	1.27	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	10.44	4.95	3.30	2.75	0.00	1.10	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	14.85	2.83	2.36	0.71	0.00	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	7.75	3.55	2.10	1.78	0.00	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	11.04	2.90	1.45	0.36	0.00	0.36	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	10.47	2.72	2.09	0.42	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	7.62	2.15	3.52	1.17	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	11.40	2.95	3.80	2.53	0.00	0.42	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	8.58	2.14	1.65	1.32	0.33	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	9.91	2.80	3.18	1.12	0.00	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	11.69	3.64	0.77	0.00	0.19	0.19	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	5.52	1.64	0.82	0.82	0.00	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	8.26	2.82	1.41	1.01	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	9.72	2.43	2.16	0.54	0.00	0.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	6.00	3.12	0.24	0.48	0.00	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	7.29	2.12	1.65	0.71	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	5.86	1.90	0.73	0.88	0.00	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	9.07	4.43	2.53	0.21	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	10.31	2.97	1.75	1.57	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	8.63	3.81	1.41	0.80	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	10.47	3.95	1.86	0.93	0.00	0.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	11.04	4.08	1.44	0.96	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	9.54	3.28	0.60	1.49	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	14.12	6.22	0.96	0.72	0.00	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	9.91	5.66	1.01	0.61	0.00	0.61	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	10.25	4.30	2.66	1.23	0.00	0.20	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	10.90	4.67	2.67	1.78	0.00	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	13.99	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	9.94	4.26	0.35	1.42	0.00	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	10.94	5.96	1.33	0.66	0.00	0.33	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	6.71	2.52	12.58	6.71	0.00	2.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	8.27	4.13	1.84	3.21	0.92	0.00	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	7.45	3.89	1.30	1.94	0.00	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	8.03	3.21	0.64	0.00	0.00	0.00	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	9.12	1.26	3.46	1.89	0.31	0.31	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	9.17	2.82	0.71	0.00	0.00	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	11.78	3.93	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	11.94	3.18	3.18	2.39	0.80	2.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	7.47	2.72	3.40	2.04	0.00	0.34	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	9.42	1.62	0.00	0.65	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	7.81	1.06	0.71	0.35	0.00	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	16.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	0.00	7.90	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	7.31	2.44	0.98	1.46	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	8.93	0.50	0.99	0.50	0.00	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	3.75	0.94	0.47	0.47	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	4.31	0.33	1.32	0.33	0.00	0.66	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	5.88	1.86	2.17	0.31	0.00	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	9.48	0.31	1.83	0.31	0.00	0.00	0.31
Adipocyte - breast, donor1	11376-118A8	7.44	2.06	1.27	0.32	0.16	0.00	0.16
Adipocyte - breast, donor2	11327-117E4	11.23	3.53	3.69	1.76	0.16	0.64	0.16
Adipocyte - omental, donor1	11473-119C6	10.31	2.80	1.27	0.38	0.13	0.00	0.25
Adipocyte - omental, donor2	11474-119C7	5.23	1.49	1.49	1.49	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	9.38	3.01	1.34	0.00	0.00	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	7.66	0.64	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	8.80	2.20	3.30	1.10	0.00	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	5.42	1.81	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	10.95	3.30	1.39	0.52	0.35	0.17	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	19.36	7.24	0.78	1.17	0.00	0.20	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	11.07	4.12	0.51	0.26	0.00	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	11.43	3.90	0.84	0.28	0.00	0.56	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	16.46	5.88	1.76	0.59	0.00	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	26.30	8.53	1.13	0.56	0.00	0.24	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	11.30	6.78	1.94	0.32	0.32	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	6.93	4.27	2.13	0.53	0.00	0.53	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	13.35	5.56	1.11	0.56	0.00	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	12.06	1.66	0.83	0.83	0.00	0.42	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	11.05	6.28	1.00	1.26	0.00	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	7.20	4.25	1.96	1.31	0.00	0.65	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	8.53	3.04	0.61	0.61	0.00	0.91	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	21.88	3.54	0.66	0.44	0.00	0.44	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	24.02	8.61	2.87	1.08	0.00	0.72	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	22.76	5.99	2.40	0.00	0.00	0.00	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	12.23	8.46	1.08	0.36	0.18	0.36	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	10.04	16.73	3.35	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	12.33	10.48	1.44	1.23	0.21	0.41	0.00
Anulus Pulposus Cell, donor1	11248-116E6	11.67	6.18	1.49	0.57	0.00	0.34	0.00
Anulus Pulposus Cell, donor2	11463-119B5	12.74	6.37	1.22	0.98	0.00	0.24	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	6.29	0.90	2.70	1.35	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	5.64	3.47	1.74	2.60	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	6.42	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	5.98	5.08	2.39	2.09	0.00	0.60	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	6.32	1.26	7.59	0.00	0.00	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	5.28	1.32	0.00	1.32	0.00	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	4.87	3.25	1.95	0.32	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	9.71	3.88	1.46	0.97	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	4.75	1.78	0.59	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	4.14	4.14	2.64	1.13	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	5.81	3.63	0.73	0.73	0.00	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	1.25	3.76	2.51	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	4.12	1.98	0.66	0.00	0.00	0.00	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	5.46	1.36	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	3.02	1.21	0.30	0.15	0.00	0.00	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	4.82	0.54	1.07	1.61	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	4.35	1.32	0.38	1.13	0.19	0.19	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	5.08	2.67	1.87	0.00	0.00	0.53	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	9.75	2.93	0.00	0.98	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	4.81	2.99	0.66	0.33	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	2.40	3.60	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	0.00	0.00	0.00	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	5.66	3.09	2.40	0.00	0.00	0.69	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	4.19	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	5.34	1.46	1.46	1.94	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	6.07	3.04	0.00	1.52	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	0.00	1.21	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	4.56	3.42	0.57	1.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	5.56	2.78	2.35	0.43	0.00	0.43	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	4.13	2.58	1.03	0.00	0.00	0.52	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	6.57	5.63	0.00	0.47	0.47	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	8.36	2.89	0.32	0.00	0.00	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	0.71	2.85	1.43	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	3.51	1.75	0.58	1.75	0.00	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	6.92	4.82	1.51	1.20	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	3.56	3.56	2.38	1.19	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	4.07	4.58	3.05	1.02	0.00	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	5.60	2.29	2.80	0.76	0.25	0.25	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	0.64	1.27	0.64	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	3.45	2.59	1.73	0.43	0.00	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	4.87	1.69	0.85	0.00	0.00	0.21	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	2.61	1.74	0.87	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	3.78	5.67	2.83	2.83	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	5.09	1.86	1.19	0.34	0.34	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	4.63	0.00	0.00	2.32	0.00	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	6.34	0.00	2.11	2.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	4.93	3.00	0.86	0.43	0.00	0.21	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	2.41	0.00	0.60	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	1.46	2.19	3.64	0.73	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	5.29	2.07	0.92	0.46	0.00	0.23	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	0.00	2.55	5.10	0.00	0.00	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	2.80	1.78	0.00	0.25	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	6.81	1.86	1.65	1.65	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	3.98	2.75	0.61	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	8.13	1.43	3.35	1.43	0.00	0.96	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	6.87	2.00	0.89	0.89	0.00	0.67	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	3.05	0.00	1.53	1.53	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	4.98	1.66	1.11	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	7.94	2.12	1.85	0.79	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	3.27	1.09	1.45	0.73	0.00	0.00	0.36
Astrocyte - cerebellum, donor1	11500-119F6	26.28	10.69	0.86	0.12	0.12	0.25	0.25
Astrocyte - cerebellum, donor2	11580-120F5	19.85	8.73	4.11	1.88	0.17	0.86	1.03
Astrocyte - cerebellum, donor3	11661-122F5	21.39	6.08	2.31	0.42	0.00	0.21	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	11.85	6.62	1.05	0.00	0.00	0.70	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	17.15	6.63	2.59	1.94	0.16	1.13	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	12.38	5.67	1.49	1.04	0.00	0.30	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	20.07	8.14	5.16	3.10	0.57	1.49	1.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	20.30	8.90	4.89	2.00	0.50	1.25	1.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	19.00	7.62	3.07	1.93	0.23	0.80	0.68
Basophils, donor1	12241-129G9	25.11	11.51	1.05	1.05	1.83	0.26	2.35
Basophils, donor2	12242-129H1	27.78	7.94	0.36	0.72	1.08	0.00	2.16
Basophils, donor3	12243-129H2	32.05	15.43	0.88	0.88	1.03	0.15	4.70
Bronchial Epithelial Cell, donor1	11511-119G8	14.66	8.19	1.08	0.22	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	26.97	9.14	4.11	2.29	0.46	0.46	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	7.17	0.00	0.00	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	16.95	5.65	0.00	0.00	0.63	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	19.13	5.20	1.04	0.21	0.00	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	20.73	7.60	1.38	0.23	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	8.64	6.12	2.52	1.08	0.00	0.18	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	17.93	14.32	1.13	1.13	0.21	0.31	0.21
Burkitt's lymphoma cell line:RAJI	10476-106I8	14.44	7.45	3.26	0.70	0.23	0.23	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	20.15	9.59	0.64	0.00	0.32	0.00	3.20
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	31.03	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	31.56	23.11	0.56	0.00	0.00	0.56	0.56
CD14+ Monocytes, donor2	11305-117B9	46.21	25.98	11.14	5.94	1.11	1.48	1.30
CD14+ Monocytes, donor3	11381-118B4	37.54	16.03	3.07	2.41	0.44	0.00	2.41
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	14.44	24.06	1.70	0.85	0.00	0.57	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	14.03	19.33	0.38	3.03	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	25.64	26.63	0.66	1.64	0.33	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	47.56	14.31	7.81	4.63	0.29	1.30	1.01
CD14+ monocytes - mock treated, donor2	11873-125C1	34.40	13.28	5.43	3.32	0.00	0.91	1.51
CD14+ monocytes - mock treated, donor3	11883-125D2	49.98	23.22	3.79	1.66	0.24	0.71	2.61
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	34.32	12.05	5.02	3.85	0.00	1.00	3.85
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	28.43	13.80	4.97	2.76	0.28	0.83	3.59
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	37.93	16.36	4.96	1.74	1.24	1.98	11.90
CD14+ monocytes - treated with BCG, donor1	11860-125A6	31.72	11.16	4.50	1.76	0.59	0.98	5.68
CD14+ monocytes - treated with BCG, donor2	11870-125B7	33.12	9.08	3.74	2.49	0.18	0.71	4.45
CD14+ monocytes - treated with BCG, donor3	11880-125C8	30.69	4.79	1.74	0.87	0.22	0.22	10.45
CD14+ monocytes - treated with Candida, donor1	11868-125B5	29.50	10.77	2.11	1.87	0.00	0.47	7.02
CD14+ monocytes - treated with Candida, donor2	11878-125C6	36.96	10.56	2.11	2.11	0.00	0.00	8.98
CD14+ monocytes - treated with Candida, donor3	11888-125D7	42.16	14.42	0.00	2.22	0.00	0.00	8.87
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	40.46	15.77	6.69	6.25	0.15	2.08	2.08
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	33.32	13.17	4.39	2.59	0.20	0.00	1.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	26.44	8.95	1.04	0.83	0.00	0.83	4.16
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	35.46	7.09	8.01	5.03	0.00	1.37	4.80
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	33.25	7.69	1.58	1.58	0.00	0.00	4.07
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	37.10	7.86	2.18	1.31	0.00	2.18	9.17
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	31.20	13.45	6.46	4.03	0.54	0.54	1.88
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	30.53	10.82	2.97	2.44	0.00	1.92	2.62
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	32.82	21.46	5.05	4.63	0.00	1.68	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	40.97	8.27	3.31	4.23	0.18	0.73	3.31
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	42.98	10.22	2.47	2.47	0.00	0.70	1.76
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	50.01	8.77	3.51	3.51	0.00	0.44	3.95
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	31.56	9.42	6.45	3.66	0.35	1.22	4.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	33.45	8.92	5.58	1.12	0.00	0.00	2.60
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	33.84	12.93	3.66	0.86	0.00	0.00	17.24
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	38.08	7.37	3.69	2.46	0.41	0.82	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	32.68	5.10	1.39	1.85	0.00	0.00	4.64
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	30.16	6.96	1.16	0.23	0.00	0.00	6.26
CD14+CD16+ Monocytes, donor1	11789-124B7	16.13	5.67	2.40	0.22	0.44	0.22	3.27
CD14+CD16+ Monocytes, donor2	11801-124D1	16.63	7.85	4.39	0.46	1.15	0.00	4.16
CD14+CD16+ Monocytes, donor3	11912-125G4	13.65	7.58	0.43	0.00	0.00	0.00	3.03
CD14+CD16- Monocytes, donor1	11788-124B6	33.64	18.69	4.05	2.65	0.93	0.31	4.67
CD14+CD16- Monocytes, donor2	11799-124C8	25.50	17.46	4.19	0.70	0.70	0.17	1.75
CD14+CD16- Monocytes, donor3	11910-125G2	49.72	25.86	6.24	1.11	2.23	1.34	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	13.27	4.08	0.77	0.26	3.32	0.51	2.04
CD14-CD16+ Monocytes, donor2	11800-124C9	15.15	4.17	1.76	0.44	3.07	0.44	1.32
CD14-CD16+ Monocytes, donor3	11911-125G3	12.21	2.95	0.63	0.21	2.53	0.00	0.63
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	10.16	2.03	2.03	0.00	0.00	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	18.98	5.42	0.00	0.00	0.00	0.68	3.39
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	15.53	11.39	0.00	0.00	0.00	0.00	3.11
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	18.12	11.19	0.53	1.07	0.53	0.00	5.33
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	16.08	10.19	1.61	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	22.46	9.83	0.00	0.00	1.40	0.00	2.11
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	15.69	4.71	1.57	0.00	2.35	0.00	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	13.18	5.27	0.00	0.00	0.00	0.00	2.64
CD19+ B Cells, donor1	11544-120B5	43.56	16.44	0.82	1.64	4.93	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	34.10	17.41	3.63	1.45	2.90	1.45	1.45
CD19+ B Cells, donor3	11705-123B4	23.73	14.14	3.53	2.02	2.02	0.50	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	30.71	2.02	2.83	0.81	12.12	0.81	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	25.57	2.00	1.20	0.80	9.19	0.40	2.00
CD34+ Progenitors, donor1	11545-120B6	26.11	10.04	0.00	0.00	0.00	1.00	1.00
CD34+ Progenitors, donor2	11625-122B5	24.72	4.49	2.25	0.56	0.00	0.00	3.37
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	18.04	15.03	0.38	0.75	0.00	0.00	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	17.36	6.76	0.68	0.45	0.00	0.00	0.90
CD4+ T Cells, donor1	11225-116C1	54.63	13.21	1.07	1.79	3.21	1.07	1.07
CD4+ T Cells, donor2	11306-117C1	28.17	11.63	14.08	3.67	1.22	1.84	0.00
CD4+ T Cells, donor3	11382-118B5	39.65	12.81	5.18	4.57	2.13	0.91	1.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	21.18	6.64	1.53	0.77	1.53	0.26	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	22.01	9.43	1.12	0.90	1.35	0.90	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	22.71	8.62	0.57	0.29	1.15	0.29	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	23.70	8.06	2.84	1.42	4.74	0.00	1.90
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	31.60	14.05	2.11	1.40	4.21	0.00	2.81
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	36.26	19.78	0.00	0.00	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	23.85	3.03	1.73	2.02	1.45	0.29	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	22.71	9.49	2.03	1.86	0.68	0.34	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	24.66	5.48	2.26	2.10	0.81	0.32	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	17.93	4.93	2.24	0.90	2.69	0.00	1.34
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	20.61	6.99	2.10	0.35	1.40	0.35	1.40
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	34.32	8.36	3.96	1.76	1.76	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	29.51	6.75	3.37	1.69	1.69	0.84	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	29.30	10.39	3.32	2.91	1.25	0.62	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	19.38	7.35	4.34	2.00	0.67	0.67	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	38.61	13.87	4.08	2.18	3.54	0.82	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	42.88	15.54	7.50	2.14	5.36	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	44.83	3.59	1.79	0.00	3.59	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	28.74	4.64	2.41	0.93	2.23	0.00	0.93
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	19.93	6.07	1.52	0.43	1.08	0.65	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	29.84	8.20	2.31	0.42	1.47	0.42	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	24.27	6.57	0.51	0.51	1.01	0.00	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	27.73	10.83	2.17	0.43	0.87	0.00	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	30.94	13.51	4.79	2.18	1.74	0.44	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	25.73	7.42	0.99	0.49	1.48	0.00	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	24.93	6.46	0.92	0.92	0.00	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	16.75	2.79	1.40	1.40	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	43.75	13.02	2.77	1.38	1.66	0.55	1.11
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	32.15	10.06	2.45	0.74	1.96	0.74	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	36.96	7.70	3.08	0.00	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	31.16	9.67	1.79	0.72	0.72	0.72	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	24.93	9.69	1.38	0.00	1.38	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	53.69	12.44	1.31	0.65	0.98	0.00	0.33
CD8+ T Cells, donor2	11307-117C2	38.67	9.01	6.01	3.75	1.88	1.50	1.50
CD8+ T Cells, donor3	11383-118B6	44.69	14.64	3.53	2.27	2.27	0.76	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	11.47	3.21	0.92	1.84	0.00	0.46	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	11.26	3.59	1.68	0.24	0.00	0.48	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	10.40	3.56	1.09	2.19	0.00	0.27	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	10.81	1.80	2.70	1.20	0.00	0.30	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	15.12	2.64	1.44	0.72	0.24	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	16.14	3.41	0.45	0.68	0.00	0.23	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	13.69	0.87	1.96	0.87	0.00	0.22	1.09
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	15.27	2.37	0.79	0.79	0.00	0.00	0.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	12.19	2.11	0.70	1.64	0.00	0.70	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	13.58	1.21	2.11	0.60	0.00	0.60	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	13.36	1.16	1.45	1.45	0.00	0.00	0.87
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	16.79	0.80	1.07	1.33	0.27	0.53	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	15.32	3.94	0.44	0.00	0.44	0.44	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	14.57	0.00	0.91	0.46	0.00	0.00	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	19.39	3.73	2.24	1.49	0.00	0.75	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	12.97	3.60	2.52	0.36	0.00	0.36	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	18.41	2.01	1.15	0.58	0.00	0.00	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	9.43	3.54	1.41	1.18	0.00	0.47	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	22.50	2.54	3.17	1.58	0.00	0.63	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	16.30	3.38	0.92	0.92	0.31	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	18.91	3.85	1.92	0.64	0.00	0.32	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	14.92	1.91	1.15	1.53	0.00	0.00	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	16.55	3.55	1.58	0.79	0.00	0.79	1.58
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	14.37	0.76	0.00	0.00	0.00	0.76	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	28.91	6.42	1.61	0.80	0.00	1.61	7.23
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	33.57	2.10	4.90	3.50	0.70	1.40	2.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	41.07	4.01	4.01	4.01	0.00	0.00	5.01
Cardiac Myocyte, donor1	11525-119I4	12.79	16.45	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	13.34	3.46	0.99	0.99	0.00	1.48	0.00
Cardiac Myocyte, donor3	11686-122I3	6.42	3.68	0.42	0.32	0.00	0.32	0.00
Chondrocyte - de diff, donor1	11261-116G1	10.75	4.85	2.08	0.69	0.00	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	9.60	2.84	0.36	0.00	0.00	0.00	0.36
Chondrocyte - de diff, donor3	11410-118E6	12.63	4.44	1.93	1.48	0.00	0.91	0.11
Chondrocyte - re diff, donor2	11339-117F7	11.64	5.37	2.69	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	17.39	6.47	0.81	0.81	0.00	0.00	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	15.03	7.34	1.26	1.03	0.00	0.23	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	10.90	5.56	2.35	0.86	0.00	0.43	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	12.21	8.14	1.86	1.06	0.00	0.18	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	45.94	20.91	2.84	2.57	3.12	1.10	2.57
Corneal Epithelial Cells, donor1	11526-119I5	23.93	7.25	1.32	0.66	0.66	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	15.93	3.41	1.14	1.14	1.14	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	17.38	6.65	2.56	1.02	0.00	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	5.45	9.25	0.66	0.17	0.17	0.17	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	8.52	7.57	1.89	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	0.00	3.45	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	5.18	6.70	1.08	0.54	0.11	0.54	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	20.16	10.93	1.37	0.34	0.68	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	16.32	1.96	1.31	0.65	0.65	0.00	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	21.29	4.84	0.97	0.00	0.00	0.00	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	19.01	12.01	0.50	0.17	0.00	0.00	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	10.56	9.98	0.59	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	16.40	11.88	0.57	0.28	0.28	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	10.62	13.37	1.57	0.79	0.39	0.79	0.00
Endothelial Cells - Artery, donor1	11264-116G4	11.05	9.89	2.04	1.75	0.29	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	20.70	12.23	4.71	2.35	0.00	1.18	0.00
Endothelial Cells - Artery, donor3	11413-118E9	18.41	11.92	1.05	1.40	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	11.08	8.20	0.22	0.66	0.00	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	8.82	13.39	1.22	0.00	0.00	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	13.53	13.25	1.13	0.56	0.00	0.56	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	11.29	9.81	0.89	0.59	0.00	0.30	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	11.45	10.41	0.00	0.00	0.00	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	16.02	12.62	2.41	1.70	0.00	0.71	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	17.21	10.00	1.60	0.80	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	11.53	11.01	4.72	2.62	0.00	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	17.02	13.54	3.48	1.37	0.12	0.62	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	15.21	14.56	2.39	0.87	0.00	0.00	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	19.30	17.10	1.22	0.98	0.37	0.24	0.00
Endothelial Cells - Vein, donor1	11267-116G7	13.65	12.51	0.00	1.14	0.00	1.14	2.28
Endothelial Cells - Vein, donor2	11344-117G3	32.13	16.07	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	14.92	9.26	0.79	0.31	0.00	0.00	0.16
Eosinophils, donor1	12244-129H3	15.25	15.25	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	169.98	89.11	6.60	1.65	9.90	0.00	23.10
Eosinophils, donor3	12246-129H5	124.84	89.17	0.00	0.00	0.00	0.00	21.40
Esophageal Epithelial Cells, donor1	11507-119G4	17.10	6.84	0.98	0.49	0.00	0.24	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	20.80	6.24	2.08	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	11.49	4.93	0.41	0.00	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	2.41	1.20	1.09	0.66	0.00	0.11	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	6.93	2.82	2.60	1.95	0.00	0.33	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	8.73	4.12	0.85	0.24	0.00	0.24	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	13.51	7.37	1.50	0.27	0.14	0.41	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	6.12	4.22	2.11	1.69	0.00	0.32	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	24.77	10.01	3.43	2.63	0.00	0.79	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	14.62	4.98	1.66	0.66	0.00	1.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	9.53	4.54	3.18	0.00	0.00	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	11.37	6.06	0.76	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	13.09	8.83	2.68	1.73	0.00	0.79	0.47
Fibroblast - Cardiac, donor4	11452-119A3	15.76	8.79	0.30	0.30	0.00	0.30	0.00
Fibroblast - Cardiac, donor5	11456-119A7	10.41	6.73	3.30	1.27	0.13	0.25	0.13
Fibroblast - Cardiac, donor6	11460-119B2	9.85	6.82	0.91	0.30	0.00	0.15	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	17.82	10.18	1.07	0.54	0.00	0.13	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	8.20	5.61	1.29	0.00	0.00	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	11.72	7.32	4.39	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	29.98	11.53	0.69	0.00	0.23	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	12.72	11.19	2.04	0.00	0.00	0.51	0.00
Fibroblast - Dermal, donor1	11269-116G9	7.51	4.70	1.17	0.70	0.00	0.23	0.00
Fibroblast - Dermal, donor2	11346-117G5	14.62	5.19	0.00	0.00	0.47	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	9.19	2.30	1.45	0.73	0.00	0.12	0.00
Fibroblast - Dermal, donor4	11450-119A1	13.57	5.43	2.60	1.13	0.11	0.79	0.45
Fibroblast - Dermal, donor5	11454-119A5	17.10	5.06	2.79	0.35	0.17	0.52	0.00
Fibroblast - Dermal, donor6	11458-119A9	16.08	4.71	2.11	1.14	0.16	0.16	0.00
Fibroblast - Gingival, donor1	11237-116D4	12.08	6.66	0.62	0.21	0.00	0.42	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	11.53	9.43	1.31	3.14	0.00	0.26	0.26
Fibroblast - Gingival, donor2	11318-117D4	13.84	3.29	3.95	1.19	0.00	0.40	0.13
Fibroblast - Gingival, donor3	11394-118C8	17.69	6.67	3.77	1.35	0.10	0.19	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	8.31	6.23	1.04	1.04	0.00	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	12.33	3.35	3.17	0.70	0.00	0.88	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	14.81	6.86	2.03	1.40	0.00	0.31	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	11.63	2.43	0.95	1.08	0.00	0.27	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	33.52	12.35	1.76	3.18	0.00	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	8.48	3.36	2.19	0.44	0.00	0.29	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	8.45	3.68	1.91	0.68	0.00	0.14	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	10.20	2.85	1.65	0.99	0.00	0.33	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	14.97	5.14	1.61	0.88	0.15	0.59	0.00
Fibroblast - Lung, donor1	11270-116H1	19.03	8.16	0.00	1.36	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	14.92	8.95	1.49	0.00	0.00	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	16.46	5.06	1.90	1.69	0.00	0.42	0.63
Fibroblast - Lymphatic, donor1	11506-119G3	82.47	15.83	0.00	0.83	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	15.38	5.59	1.40	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	16.23	5.88	3.08	1.40	0.00	0.84	0.28
Fibroblast - Mammary, donor1	11540-120B1	47.90	12.99	0.81	0.41	0.00	0.41	0.41
Fibroblast - Mammary, donor2	11620-122A9	23.97	19.97	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	5.96	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	11.83	4.27	1.36	0.78	0.00	0.39	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	23.51	9.25	6.98	3.79	0.15	1.06	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	24.17	5.51	0.61	0.61	0.31	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	10.30	3.82	0.38	0.38	0.00	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	7.56	2.16	2.43	0.27	0.27	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	9.97	2.78	0.70	0.70	0.00	0.12	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	5.86	3.43	0.99	0.33	0.11	0.22	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	36.98	10.16	1.02	0.81	0.20	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	17.37	4.68	2.00	0.67	0.00	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	12.26	3.56	0.79	0.00	0.00	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	25.20	6.95	4.37	2.18	0.40	0.60	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	11.37	3.55	1.24	0.71	0.18	0.18	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	13.40	3.35	0.59	0.59	0.20	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	23.17	4.81	1.20	2.11	0.00	0.30	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	15.87	4.64	2.48	0.97	0.11	0.43	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	25.81	7.85	6.33	1.27	0.00	1.01	0.00
Fibroblast - skin normal, donor1	11553-120C5	12.31	3.28	1.31	0.82	0.00	0.33	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	30.48	9.62	1.20	0.60	0.40	0.60	0.00
Fibroblast - skin normal, donor2	11561-120D4	10.25	5.12	2.91	0.80	0.10	0.30	0.30
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	30.22	10.88	4.84	2.12	0.60	0.60	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	13.92	4.72	0.66	0.83	0.08	0.17	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	13.85	7.86	3.93	1.03	0.51	0.17	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	20.03	5.91	1.97	0.33	0.33	0.66	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	11.61	5.22	1.70	0.64	0.11	0.21	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	12.99	2.36	0.84	0.00	0.00	0.17	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	6.12	1.88	3.76	2.35	0.00	0.78	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	18.30	12.20	1.74	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	7.45	2.60	0.00	0.00	0.17	0.00	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	10.93	7.03	0.26	0.52	0.00	0.26	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	11.75	4.85	0.26	0.77	0.00	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	5.36	7.66	2.30	2.30	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	5.74	3.19	1.91	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	13.41	5.71	2.57	1.14	0.57	1.14	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	30.61	6.89	3.58	1.93	0.83	0.83	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	24.43	20.55	2.28	2.51	0.46	0.46	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	13.87	5.94	4.16	1.19	0.40	0.20	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	24.32	7.67	4.76	2.64	0.53	0.53	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	22.18	31.64	2.28	0.33	0.33	0.00	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	8.40	7.08	5.31	1.33	0.88	0.44	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	27.84	12.15	4.66	2.54	0.71	0.57	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	18.59	10.22	1.35	2.83	0.62	0.62	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	20.68	8.86	4.03	1.88	0.27	0.54	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	14.37	7.19	1.36	1.61	0.00	0.25	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	12.46	8.31	3.32	1.38	0.00	0.69	0.69
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	13.82	7.93	3.25	2.03	0.20	0.61	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	12.09	7.99	2.05	2.05	0.00	0.46	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	11.58	5.98	2.87	0.25	0.12	0.37	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	12.90	10.93	1.53	0.44	0.00	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	18.02	10.05	2.36	1.77	0.00	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	18.92	13.67	3.18	1.59	0.32	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	16.98	11.39	2.46	0.67	0.22	0.45	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	17.74	12.30	6.25	2.42	0.60	0.81	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	21.54	11.54	4.07	2.37	0.68	0.51	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	23.32	13.12	1.60	2.04	0.35	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	37.15	15.92	1.56	3.64	0.42	0.94	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	34.33	14.52	0.68	1.88	0.17	0.51	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	23.24	11.51	2.32	1.22	0.22	0.55	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	21.05	9.32	1.50	1.08	0.33	0.42	0.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	18.38	11.64	0.61	0.61	0.00	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	21.46	8.46	4.13	1.65	0.00	0.62	0.83
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	23.75	11.41	3.46	1.84	0.35	1.04	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	23.01	11.01	4.84	1.50	0.17	0.67	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	18.74	10.14	3.75	1.98	0.22	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	28.17	9.96	4.18	1.60	0.37	0.61	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	29.50	12.48	2.59	2.92	0.00	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	21.49	9.30	3.53	1.92	0.00	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	20.85	10.71	2.65	2.18	0.47	0.28	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	20.72	5.54	1.58	1.90	0.16	0.63	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	15.51	7.60	2.43	2.13	0.00	1.22	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	22.89	9.51	2.82	1.99	0.00	0.52	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	18.66	6.37	2.63	0.22	0.22	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	21.60	6.73	3.93	2.24	0.56	1.12	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	23.15	8.70	1.85	1.11	0.00	0.19	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	18.72	7.75	2.67	0.80	0.00	0.80	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	21.27	6.12	2.60	1.68	0.15	0.46	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	18.39	7.38	2.33	1.55	0.39	0.78	0.65
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	18.98	6.51	2.17	1.90	0.00	0.54	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	17.33	6.82	3.87	2.03	0.18	0.55	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	21.71	7.46	2.85	1.10	0.44	1.10	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	35.70	25.79	6.94	2.98	0.00	1.98	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	23.61	8.44	2.51	1.98	0.00	0.79	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	15.94	4.84	1.61	2.02	0.20	0.40	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	79.04	38.38	3.56	3.81	1.02	1.78	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	22.10	7.56	3.58	0.40	1.19	0.60	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	24.04	9.55	3.39	2.31	1.08	0.92	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	22.91	9.21	3.48	1.64	1.23	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	7.20	2.82	0.31	0.00	0.00	0.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	5.65	2.54	0.57	0.00	0.57	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	7.84	4.61	1.38	2.77	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	2.47	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	8.90	5.80	3.09	0.77	0.39	0.77	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	11.23	4.81	0.00	1.60	0.00	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	15.65	10.43	3.48	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	8.79	2.93	2.28	1.95	0.65	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	12.77	8.24	4.12	2.06	0.41	0.82	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	13.33	6.66	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	10.07	5.59	2.24	0.28	0.28	0.28	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	13.07	6.21	0.65	2.61	0.33	0.65	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	9.23	5.87	4.19	3.36	0.84	0.00	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	13.68	6.68	3.82	2.54	0.32	0.32	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	7.81	5.43	3.74	1.02	0.00	0.34	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	6.26	2.09	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	16.61	9.16	2.86	2.86	0.00	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	13.62	6.22	0.59	0.89	0.00	0.30	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	1.69	13.55	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	15.74	6.21	4.97	1.24	1.66	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	12.43	7.13	1.84	1.15	0.23	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	15.81	5.27	5.27	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	10.38	3.84	2.69	1.54	0.00	0.00	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	8.15	7.82	3.26	0.65	0.33	0.33	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	4.01	4.68	0.67	0.00	0.00	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	14.25	10.40	4.24	2.70	0.39	1.93	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	24.65	14.72	4.45	1.03	0.34	0.68	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	12.42	4.97	2.48	2.48	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	16.99	10.38	4.72	3.30	0.47	0.00	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	10.26	9.66	6.03	3.02	1.81	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	12.72	9.16	0.00	0.00	0.00	0.00	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	12.36	7.58	4.39	0.00	0.00	0.80	1.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	13.32	6.91	3.45	1.97	0.00	1.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	16.53	3.54	4.72	0.00	0.00	1.18	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	9.34	8.17	2.92	0.58	0.00	1.17	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	16.68	7.02	2.63	0.88	0.88	0.00	1.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	15.26	8.48	2.54	1.70	0.85	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	10.15	8.95	4.18	1.19	0.00	1.79	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	8.73	7.76	2.43	2.43	0.49	1.46	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	7.99	2.28	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	17.05	4.99	5.82	2.49	0.42	0.83	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	12.37	5.62	1.12	2.25	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	10.78	4.12	3.49	0.32	0.32	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	6.27	0.00	0.42	0.00	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	8.94	2.09	1.86	1.04	0.58	0.23	0.23
Hep-2 cells mock treated, biol_rep2	11899-125E9	11.65	2.70	3.21	1.35	0.34	0.51	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	13.20	2.05	1.14	0.91	0.23	0.46	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	12.35	1.97	2.30	1.31	0.55	0.44	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	9.67	1.93	1.93	0.21	0.43	0.21	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	9.26	1.29	1.51	1.08	0.43	0.22	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	12.33	1.37	1.00	0.62	0.50	0.37	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	12.52	1.54	0.86	0.51	0.00	0.17	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	6.09	1.92	0.96	0.64	0.00	0.32	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	15.67	14.55	1.68	0.56	0.00	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	15.58	9.52	1.30	0.43	0.00	0.43	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	13.22	13.22	5.29	2.64	0.00	5.29	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	16.23	13.05	0.35	0.00	0.00	0.35	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	5.81	8.72	0.73	2.18	0.73	1.45	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	9.62	3.15	2.45	0.87	0.17	0.35	0.17
Hepatocyte, donor1	11523-119I2	32.69	13.32	6.05	4.84	2.42	4.84	0.00
Hepatocyte, donor2	11603-120I1	40.94	11.85	7.54	2.15	0.00	1.08	0.00
Hepatocyte, donor3	11684-122I1	17.79	9.20	3.07	3.68	1.23	1.23	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	28.72	13.05	5.87	4.57	1.31	1.31	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	31.64	12.23	4.37	1.57	1.05	0.35	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	8.78	6.45	0.96	0.82	0.00	0.27	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	12.74	3.18	6.37	3.18	0.00	0.00	12.74
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	33.38	6.68	6.68	0.00	0.00	0.00	13.35
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	0.00	0.00	0.00	0.00	27.08
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	12.46	6.92	0.00	1.38	0.00	0.00	8.31
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	27.53	0.00	0.00	5.01	0.00	0.00	15.02
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	23.74	0.00	0.00	0.00	0.00	23.74
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	33.32	7.69	2.56	2.56	0.00	0.00	12.81
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	27.42	13.71	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	17.87	12.99	3.25	3.25	1.62	3.25	8.12
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	15.01	5.00	1.67	3.33	1.67	0.00	11.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	29.04	10.89	3.63	3.63	0.00	3.63	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	31.76	7.94	6.62	2.65	0.00	0.00	9.26
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	7.76	9.98	1.11	2.22	1.11	0.00	11.09
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	36.67	10.48	0.00	0.00	0.00	0.00	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	18.90	6.30	3.15	1.89	0.00	0.00	5.04
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	17.01	7.73	3.09	0.00	1.55	0.00	15.47
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	14.63	0.00	0.00	0.00	0.00	29.27
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	22.61	8.40	5.81	2.58	0.00	0.65	7.11
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	32.20	9.66	1.61	1.61	0.00	0.00	9.66
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	11.95	0.00	0.00	0.00	0.00	23.90
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	29.34	10.59	1.63	0.81	0.81	0.81	2.44
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	17.63	5.04	1.26	0.00	0.00	0.00	2.10
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	22.50	8.04	1.61	0.00	0.00	0.80	6.43
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	20.31	6.46	0.00	0.00	0.00	0.92	3.69
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	15.08
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	11.80	5.19	1.42	0.94	0.00	0.94	1.89
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	14.51	2.72	1.81	1.81	0.91	0.00	2.72
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	29.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	20.45	7.53	4.30	1.08	0.00	0.00	6.46
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	24.14	13.98	0.00	0.00	0.00	0.00	6.35
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	21.04	7.01	3.83	1.28	0.00	0.64	7.65
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	21.87	7.29	1.82	1.82	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	24.28	8.57	6.43	0.71	0.00	0.00	4.28
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	13.27	6.64	3.32	0.00	0.00	0.00	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	14.20	6.17	4.32	1.54	0.00	0.00	2.78
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	28.10	14.05	1.76	1.76	0.00	0.00	7.02
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	22.00	3.14	0.00	0.00	0.00	0.00	6.29
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	25.03	4.87	3.48	2.09	0.00	0.00	8.34
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	46.47	19.92	0.00	4.43	2.21	0.00	4.43
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	25.94	3.24	6.48	0.00	0.00	0.00	9.73
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	35.75	11.34	6.98	2.62	0.00	1.74	6.10
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	38.25	11.25	2.25	4.50	0.00	0.00	4.50
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	45.30	17.42	3.48	3.48	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	42.67	14.93	6.40	3.20	0.00	1.07	3.20
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	23.55	12.47	0.00	1.39	0.00	1.39	8.31
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	14.25	5.70	2.85	0.00	0.00	5.70	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	31.29	11.97	2.76	1.84	0.00	0.00	5.52
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	45.38	21.18	9.08	0.00	0.00	0.00	15.13
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	12.42	0.00	0.00	0.00	12.42	24.83
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	47.58	11.63	5.29	5.29	0.00	1.06	8.46
Keratinocyte - epidermal, donor1	11272-116H3	12.24	8.08	1.71	1.14	0.08	0.82	0.00
Keratinocyte - epidermal, donor2	11349-117G8	18.15	5.27	0.59	0.00	0.00	0.00	0.59
Keratinocyte - epidermal, donor3	11421-118F8	15.52	5.11	1.70	1.70	0.09	0.76	0.00
Keratinocyte - oral, donor1	11251-116E9	24.18	7.72	2.27	1.02	0.23	0.68	0.11
Keratocytes, donor1	11527-119I6	25.79	8.94	0.69	0.69	0.34	0.00	0.34
Keratocytes, donor2	11607-120I5	12.89	3.52	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	9.29	4.94	1.58	0.79	0.00	0.40	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	41.76	35.17	2.20	2.20	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	9.71	5.39	2.16	1.08	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	15.57	5.88	1.15	0.92	0.12	0.23	0.00
Lens Epithelial Cells, donor3	11690-122I7	7.27	5.55	0.30	0.30	0.00	0.00	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	10.08	6.64	1.66	1.19	0.12	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	9.77	3.07	1.40	0.28	0.00	0.00	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	9.13	6.14	2.05	1.57	0.00	0.79	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	9.14	4.30	1.08	1.08	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	12.29	4.41	0.95	0.32	0.00	0.32	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	9.27	7.33	2.48	0.86	0.22	0.43	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	6.98	5.75	0.82	0.41	0.00	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	10.11	3.79	1.26	0.51	0.00	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	8.87	6.05	3.24	1.41	0.14	0.99	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	3.96	3.96	0.79	1.98	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	9.50	4.07	1.16	1.16	0.19	0.00	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	7.96	4.81	1.85	0.74	0.00	0.37	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	9.06	8.36	3.14	0.70	0.00	1.39	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	14.31	4.05	0.95	0.24	0.00	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	9.20	4.12	1.65	1.51	0.00	0.82	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	8.93	7.08	0.92	1.23	0.00	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	8.11	1.87	0.62	0.31	0.00	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	13.36	7.50	1.28	0.55	0.00	0.37	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	6.25	6.58	0.99	0.33	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	12.59	3.22	1.46	0.88	0.29	0.59	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	9.96	9.46	2.49	0.75	0.00	0.75	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	9.21	6.79	0.00	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	8.35	2.96	1.08	0.54	0.00	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	11.20	4.54	1.82	1.97	0.00	0.45	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	3.11	4.15	0.52	1.04	0.00	0.00	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	10.47	3.98	1.47	0.63	0.00	0.21	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	8.57	5.26	2.86	0.60	0.15	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	8.25	6.88	1.38	1.38	0.00	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	7.34	2.07	0.94	0.38	0.19	0.00	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	8.80	6.68	2.33	1.48	0.00	0.42	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	8.24	8.72	1.45	0.00	0.48	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	7.94	3.31	1.32	0.00	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	7.43	7.06	2.60	1.61	0.00	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	11.85	7.40	1.48	0.37	0.00	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	3.71	1.48	0.25	0.74	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	7.42	6.87	1.65	1.10	0.00	0.14	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	8.36	4.18	0.64	1.61	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	7.30	2.74	0.91	0.30	0.00	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	10.36	6.44	1.40	0.70	0.14	0.42	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	5.33	5.33	1.07	1.42	0.00	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	5.82	2.42	3.39	0.97	0.00	0.00	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	10.43	7.62	1.09	0.47	0.00	0.62	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	8.24	6.45	2.51	1.07	0.00	0.36	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	10.13	2.61	1.63	1.31	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	7.77	4.47	1.88	0.71	0.24	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	12.00	8.66	1.49	1.24	0.00	0.87	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	9.99	2.82	0.26	0.26	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	8.65	8.35	1.19	0.60	0.30	0.90	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	15.86	36.26	2.27	0.00	0.00	0.00	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	19.95	25.32	5.37	3.07	2.30	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	20.78	14.84	1.48	2.97	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	24.12	14.39	6.77	2.96	0.85	1.27	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	15.47	18.29	3.52	3.52	2.11	0.70	2.81
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	22.42	14.94	4.67	1.87	0.93	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	17.00	20.10	12.37	4.12	0.52	1.55	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	21.41	21.41	5.95	2.38	0.00	0.00	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	17.19	17.42	1.58	1.58	1.58	1.13	0.68
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	13.96	13.96	5.53	3.78	0.87	2.04	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	15.31	19.36	7.65	2.25	0.45	1.80	1.35
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	30.76	32.52	3.79	1.90	1.22	1.35	0.68
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	17.46	22.08	8.22	3.08	1.03	1.03	1.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	21.17	19.05	3.88	1.06	1.76	1.76	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	14.66	11.33	3.33	2.00	1.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	21.90	19.36	13.75	7.13	0.00	1.53	5.09
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	22.41	19.48	4.54	1.07	1.07	0.80	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	23.43	19.08	7.56	4.16	1.13	0.94	0.94
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	18.41	21.47	9.20	3.07	1.23	1.84	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	29.36	25.28	11.42	5.71	4.08	4.89	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	19.16	17.49	11.45	6.25	0.62	3.33	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	17.38	15.41	13.73	3.36	0.56	2.24	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	24.73	34.00	9.27	6.18	2.06	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	24.39	24.68	13.35	7.26	1.16	4.35	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	13.75	17.04	6.58	5.68	0.60	1.79	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	24.34	17.70	4.43	3.32	1.11	2.21	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	38.18	29.69	15.55	7.42	1.06	3.53	1.06
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	23.23	16.60	6.64	4.43	0.74	3.69	1.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	18.42	23.03	9.21	4.61	0.00	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	27.25	26.10	10.36	8.06	1.15	2.69	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	24.91	26.61	15.29	10.76	2.26	3.96	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	25.43	26.25	4.10	3.28	0.82	1.64	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	27.56	20.79	8.59	6.33	2.26	2.71	1.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	27.29	21.54	5.03	2.15	0.00	2.15	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	25.39	22.41	4.48	2.24	0.00	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	31.59	23.41	23.04	8.92	0.37	6.69	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	18.52	20.25	3.45	1.29	0.43	0.43	2.15
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	37.68	19.69	4.28	4.28	0.86	2.57	3.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	31.32	25.99	17.66	5.33	0.33	5.33	1.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	24.13	30.17	7.84	7.24	0.00	3.02	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	22.04	27.02	5.69	3.55	0.71	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	28.53	25.78	10.66	3.78	0.00	1.03	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	34.89	24.69	6.98	3.22	0.00	3.76	2.68
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	28.28	26.26	7.41	10.10	0.00	1.35	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	32.97	28.52	17.41	10.74	0.37	3.70	2.59
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	8.14	13.96	2.33	0.00	0.00	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	17.98	19.04	6.35	1.06	0.00	3.17	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	28.01	30.81	11.20	6.00	2.80	2.00	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	17.44	22.53	7.27	5.09	0.73	0.73	2.18
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	29.89	17.63	4.60	3.83	0.00	1.53	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	23.18	24.17	9.87	7.89	0.49	0.99	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	19.76	25.41	9.41	3.76	0.94	1.88	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	27.66	31.17	4.53	3.02	0.50	0.50	2.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	24.78	20.28	11.72	3.15	0.45	4.06	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	25.82	13.77	5.16	10.33	1.72	5.16	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	25.83	31.62	12.91	4.01	1.34	2.67	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	31.28	27.37	10.56	7.82	0.00	3.91	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	17.81	24.41	9.24	1.32	0.00	3.30	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	29.58	25.43	6.23	4.15	1.04	1.04	2.08
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	27.57	26.25	17.94	9.19	1.31	4.81	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	19.57	19.57	3.35	1.12	1.12	1.68	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	30.03	32.68	4.86	2.21	1.32	1.77	2.21
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	23.91	27.00	11.57	4.63	0.77	1.54	1.54
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	15.70	15.19	9.11	4.56	0.51	2.03	1.52
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	23.55	23.07	8.17	1.92	0.96	0.48	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	25.44	29.02	7.55	4.37	1.59	1.99	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	17.62	21.87	9.72	5.47	2.43	0.61	2.43
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	20.75	18.68	9.68	2.77	2.08	2.08	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	32.68	24.70	15.20	6.08	0.00	2.66	1.90
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	19.62	18.07	5.68	5.68	1.55	1.55	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	23.58	27.81	6.65	7.86	2.42	3.63	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	32.96	25.67	11.73	4.44	1.90	2.85	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	30.39	15.99	10.13	4.26	2.67	2.67	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	22.41	20.69	8.05	2.30	1.72	1.15	2.87
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	33.94	20.57	13.88	8.23	0.51	3.60	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	28.29	16.27	8.49	5.66	0.71	4.95	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	28.37	24.40	10.21	3.97	1.70	2.84	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	42.43	24.96	14.56	9.15	1.66	4.16	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	28.19	16.44	10.96	7.83	0.00	2.35	2.35
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	26.72	16.70	6.26	5.85	0.00	2.51	2.09
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	41.35	26.48	15.33	4.65	0.93	3.25	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	22.75	19.40	8.03	10.04	0.00	0.67	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	24.59	21.92	8.55	5.88	0.00	1.60	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	25.86	29.50	15.36	4.85	0.40	4.04	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	23.86	22.03	5.51	0.00	0.00	1.84	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	28.45	26.67	16.00	3.56	0.89	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	34.19	27.35	7.41	7.41	0.00	0.00	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	26.84	30.68	10.74	3.83	0.00	3.83	3.07
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	23.53	20.79	10.94	8.21	0.55	1.09	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	37.42	30.29	10.25	4.01	0.45	1.34	4.01
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	34.57	32.23	3.12	2.60	0.26	1.30	0.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	37.13	27.85	7.29	5.97	0.66	1.33	2.65
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	39.49	29.10	10.39	0.00	0.00	2.08	4.16
Macrophage - monocyte derived, donor1	11232-116C8	8.89	15.73	0.46	0.23	0.00	0.23	0.23
Macrophage - monocyte derived, donor2	11313-117C8	3.30	4.40	0.18	0.37	0.00	0.00	0.55
Macrophage - monocyte derived, donor3	11389-118C3	6.95	8.26	1.97	0.66	0.00	0.13	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	3.72	1.59	0.00	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	10.93	3.33	1.43	0.63	0.00	0.95	0.00
Mallassez-derived cells, donor3	11930-125I4	8.06	2.92	1.53	0.56	0.00	0.56	0.00
Mammary Epithelial Cell, donor1	11273-116H4	12.95	3.49	0.60	0.50	0.00	0.50	0.10
Mammary Epithelial Cell, donor2	11350-117G9	13.03	4.63	1.45	0.87	0.00	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	15.96	10.73	0.25	0.75	0.00	0.75	0.00
Mast cell - stimulated, donor1	11487-119E2	17.63	12.20	6.78	5.42	0.00	0.68	0.00
Mast cell, donor1	11563-120D6	28.98	17.30	1.84	1.62	0.22	0.54	0.32
Mast cell, donor2	11565-120D8	58.54	48.44	3.86	2.97	0.89	0.89	3.57
Mast cell, donor3	11566-120D9	65.29	48.85	4.05	4.73	0.90	0.90	4.73
Mast cell, donor4	11567-120E1	62.41	47.87	1.60	3.37	0.53	0.71	4.43
Mast cell, expanded and stimulated, donor5	11940-126A5	38.04	10.42	4.44	2.99	0.00	1.00	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	29.18	4.67	3.50	4.67	0.00	0.58	0.58
Mast cell, expanded, donor5	11939-126A4	32.93	15.37	4.02	2.87	0.11	1.03	0.46
Mast cell, expanded, donor8	11941-126A6	53.56	17.57	4.18	4.02	0.17	0.84	0.33
Melanocyte - dark, donor1	11502-119F8	12.24	5.17	0.50	0.60	0.10	0.20	0.00
Melanocyte - dark, donor2	11582-120F7	11.07	6.92	2.08	1.38	0.00	0.35	0.35
Melanocyte - dark, donor3	11663-122F7	24.12	6.74	1.59	0.22	0.07	0.43	0.14
Melanocyte - light, donor1	11274-116H5	28.21	7.99	1.18	0.47	0.00	0.47	0.94
Melanocyte - light, donor2	11351-117H1	25.93	5.46	1.36	1.36	0.00	0.68	1.36
Melanocyte - light, donor3	11423-118G1	24.28	10.41	2.60	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	21.97	5.73	2.92	1.87	0.00	1.15	0.21
Melanocyte, donor2 (MC+2)	12739-135I3	13.18	6.19	0.27	1.61	0.00	0.81	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	34.55	12.86	4.29	2.68	0.00	1.07	0.00
Meningeal Cells, donor1	11493-119E8	28.29	12.65	0.62	0.74	0.12	0.37	0.50
Meningeal Cells, donor2	11573-120E7	22.01	12.76	1.76	1.32	0.00	0.88	0.44
Meningeal Cells, donor3	11654-122E7	12.55	6.19	1.55	0.90	0.08	0.41	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	9.70	2.28	0.29	0.29	0.00	0.57	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	9.86	5.84	0.60	0.40	0.00	0.20	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	34.17	19.71	0.00	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	17.01	3.92	0.00	2.62	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	15.79	2.87	2.15	0.00	0.00	0.72	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	10.59	4.87	1.06	1.27	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	11.06	7.54	1.01	1.01	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	17.80	3.96	0.66	0.00	0.00	0.44	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	19.00	2.19	1.46	0.73	0.00	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	15.55	4.91	1.64	0.82	0.00	0.20	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	10.25	4.71	1.11	0.14	0.00	0.14	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	16.73	13.75	0.74	1.86	0.00	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	16.05	3.42	2.11	1.32	0.13	0.79	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	19.88	7.42	0.59	0.59	0.00	0.59	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	11.68	7.01	7.01	2.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	20.49	5.76	1.92	0.64	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	10.63	4.25	1.06	0.00	0.00	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	15.01	3.13	0.94	0.00	0.00	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	7.98	4.35	2.18	0.73	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	5.04	3.98	1.33	0.53	0.27	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	4.50	3.50	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	10.41	6.36	1.37	1.73	0.07	0.65	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	6.75	12.15	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	7.14	10.84	0.99	1.48	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	6.18	9.72	0.00	0.59	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6.91	10.37	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	5.27	7.13	0.62	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	5.39	6.22	0.00	0.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	2.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	5.76	7.76	1.00	1.50	0.25	0.25	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	5.59	8.38	0.93	0.93	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	19.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	7.32	7.11	1.02	0.81	0.00	0.00	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	3.96	9.11	0.00	0.40	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	8.55	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	7.08	4.42	3.54	0.88	0.00	0.00	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	3.04	2.66	0.38	0.00	0.00	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	6.58	3.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	5.52	5.73	1.06	0.64	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	1.84	1.84	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	4.77	4.47	0.30	0.30	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	3.35	5.03	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	4.01	3.76	0.75	0.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	4.28	4.04	0.24	0.00	0.00	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	4.42	2.76	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	1.61	1.38	0.46	0.69	0.00	0.00	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	3.79	4.63	0.00	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	3.87	3.47	0.61	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	2.15	3.22	0.43	0.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	3.11	3.11	1.33	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	1.75	1.31	0.00	0.00	0.00	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	2.03	3.04	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	3.31	3.31	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	5.44	2.72	0.54	0.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	4.41	2.06	0.00	0.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	5.45	2.18	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	3.36	0.96	0.00	0.48	0.00	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	4.80	4.40	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	5.48	6.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	3.50	1.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	6.12	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	1.75	2.19	0.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	3.31	2.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	3.84	8.97	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	5.45	2.23	0.74	0.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	4.87	2.09	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	8.84	11.05	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	6.50	4.79	1.03	0.34	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	7.00	3.06	0.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	8.52	6.39	0.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	4.77	1.68	0.28	0.00	0.00	0.28	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	4.99	1.66	0.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	6.41	3.50	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	7.54	2.41	1.21	0.60	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	4.17	2.09	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	7.22	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	4.62	1.85	0.92	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	3.98	5.12	0.57	0.57	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	8.71	4.56	0.83	0.41	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	8.81	1.81	1.04	0.26	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	6.01	3.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	7.62	2.54	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	9.34	3.47	0.27	0.00	0.00	0.00	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	5.69	6.88	0.30	0.60	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	8.76	4.80	0.99	0.57	0.00	0.14	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	4.78	2.55	0.32	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	6.86	3.32	0.44	0.44	0.00	0.22	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	7.58	4.55	1.52	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	7.95	2.84	0.00	0.28	0.00	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	6.15	2.70	0.25	0.49	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	10.43	5.87	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	7.94	1.76	0.59	0.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	8.07	3.75	0.86	0.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	9.48	7.83	0.82	0.82	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	8.64	3.87	0.30	0.30	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	11.30	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	7.56	3.94	2.63	1.64	0.33	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	3.16	8.42	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	5.73	6.52	0.99	0.20	0.00	0.00	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	0.93	6.52	0.00	0.00	0.00	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	6.76	4.51	2.25	0.75	0.00	0.00	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	2.13	5.59	0.53	0.53	0.00	0.00	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	5.88	3.96	0.23	0.23	0.00	0.00	0.45
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	4.42	5.16	0.74	0.74	0.00	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	7.69	4.76	1.83	0.37	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	0.00	3.11	6.22	1.56	0.00	3.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	2.67	4.81	0.00	0.00	0.00	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	3.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	8.08	0.00	0.00	1.01	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	4.64	1.69	0.00	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	0.00	1.36	0.00	0.00	0.00	0.00	2.72
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	0.81	0.00	0.00	0.00	0.00	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	1.51	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	28.55	5.71	0.00	0.00	0.00	0.00	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	6.52	6.52	0.00	0.00	0.00	0.00	9.79
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	14.26	0.00	0.00	0.00	0.00	9.50
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00	0.00	0.00	0.00	25.10
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	9.91	3.45	1.08	0.22	0.00	0.43	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	12.02	5.75	1.57	1.57	0.00	1.05	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	6.67	2.67	0.67	0.67	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	3.34	5.01	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	7.80	2.09	3.99	0.95	0.00	0.57	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	22.34	6.38	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	4.08	3.40	0.68	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	16.54	0.00	5.51	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	4.19	1.67	1.26	0.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	3.72	2.09	0.70	0.23	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	9.19	4.86	0.81	0.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	12.82	5.26	1.68	1.47	0.00	0.21	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	0.00	11.13	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	8.93	4.47	0.50	0.50	0.99	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	2.98	1.62	0.54	0.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	3.17	2.49	0.68	0.23	0.23	0.45	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	7.19	2.61	1.63	0.16	0.00	0.16	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	12.03	5.47	3.46	1.64	0.00	0.91	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	5.83	2.12	2.65	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	6.00	3.60	0.00	0.00	0.00	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	4.92	1.64	3.28	2.30	0.00	1.31	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	5.04	1.79	0.98	0.16	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	18.52	4.23	4.76	1.59	0.00	0.71	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	3.52	1.41	0.70	0.70	0.00	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	6.44	2.76	1.38	1.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	6.75	2.25	1.61	0.00	0.00	0.32	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	7.24	2.76	6.55	2.76	0.34	1.03	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	27.81	5.06	10.11	15.17	0.00	5.06	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	11.58	6.46	1.34	0.89	0.00	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	7.20	3.39	0.42	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	4.51	1.19	1.42	0.47	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	7.73	2.15	0.86	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	0.00	27.08	9.03	0.00	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	8.66	4.67	2.33	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	8.12	2.71	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	3.57	1.59	0.40	0.00	0.00	1.19	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	4.64	0.00	0.00	0.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	2.65	1.14	0.00	0.76	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	6.19	5.87	1.63	0.00	0.65	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	8.28	4.79	0.87	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	12.66	3.62	0.90	0.90	0.45	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	2.65	1.76	0.00	0.00	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	3.99	1.99	0.66	1.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	7.94	3.97	2.48	0.50	0.50	1.49	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	8.04	3.45	1.15	1.15	0.00	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	9.68	2.42	2.12	0.30	0.00	0.91	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	9.50	3.09	1.77	0.44	0.00	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	4.07	0.00	0.68	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	4.88	2.44	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	5.35	4.41	1.26	1.26	0.31	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	9.68	4.54	0.61	0.91	0.00	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	4.75	0.79	1.58	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	9.07	4.53	5.67	3.40	0.00	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	15.17	5.06	10.12	5.06	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	5.59	3.11	0.62	0.37	0.12	0.25	0.00
Myoblast, donor2	11322-117D8	11.12	3.84	2.69	1.92	0.00	0.77	0.38
Myoblast, donor3	11398-118D3	10.59	5.72	0.50	0.17	0.34	0.00	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	20.43	10.22	0.58	0.88	0.15	0.44	0.15
Natural Killer Cells, donor1	11230-116C6	51.66	16.91	1.23	0.62	3.08	0.62	1.85
Natural Killer Cells, donor2	11311-117C6	38.60	10.55	8.44	4.22	1.21	1.51	3.62
Natural Killer Cells, donor3	11387-118C1	46.75	12.88	3.13	1.47	2.02	1.66	4.23
Neural stem cells, donor1	11275-116H6	27.58	13.43	2.18	3.27	0.36	1.81	0.00
Neural stem cells, donor2	11352-117H2	36.59	17.33	3.85	0.00	0.00	1.93	0.00
Neurons, donor1	11494-119E9	17.07	4.55	4.55	3.41	0.00	3.41	0.00
Neurons, donor2	11574-120E8	9.25	5.06	1.10	0.88	0.22	0.44	0.44
Neurons, donor3	11655-122E8	11.51	4.93	4.93	2.47	0.00	0.82	1.64
Neutrophils, donor1	11233-116C9	111.36	77.02	41.76	29.70	5.57	7.42	3.71
Neutrophils, donor2	11314-117C9	136.25	78.27	95.66	66.67	5.80	28.99	5.80
Neutrophils, donor3	11390-118C4	171.04	158.21	17.71	25.04	4.89	7.94	11.00
Nucleus Pulposus Cell, donor1	11252-116F1	17.45	4.99	1.07	2.14	0.12	1.07	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	13.35	6.84	2.93	0.98	0.00	0.65	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	8.22	3.61	0.60	0.80	0.00	0.40	0.00
Olfactory epithelial cells, donor1	11933-125I7	13.35	4.54	3.99	2.06	0.14	0.28	0.00
Olfactory epithelial cells, donor2	11934-125I8	11.87	6.37	10.42	4.49	0.00	1.45	0.00
Olfactory epithelial cells, donor3	11935-125I9	17.14	6.36	4.99	1.48	0.00	0.57	0.00
Olfactory epithelial cells, donor4	11936-126A1	14.90	5.06	2.43	1.56	0.10	0.29	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	16.25	4.21	0.60	0.00	0.60	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	8.93	3.19	0.21	0.21	0.00	0.00	0.43
Osteoblast - differentiated, donor2	11353-117H3	8.00	4.57	1.14	1.14	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	13.66	6.21	0.00	1.24	0.62	0.00	0.00
Osteoblast, donor1	11277-116H8	14.85	9.19	0.20	0.20	0.39	0.20	0.78
Osteoblast, donor2	11354-117H4	9.13	7.02	2.11	0.70	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	11.37	5.87	0.53	0.18	0.00	0.18	0.18
Pancreatic stromal cells, donor1	11249-116E7	11.88	4.46	1.85	0.67	0.00	0.25	0.08
Pericytes, donor1	11491-119E6	22.59	13.46	1.78	0.67	0.33	0.33	0.33
Pericytes, donor2	11571-120E5	18.11	16.52	4.30	0.45	0.00	1.36	0.23
Pericytes, donor3	11652-122E5	12.82	7.73	2.44	0.81	0.00	0.61	0.20
Perineurial Cells, donor1	11499-119F5	13.79	5.76	1.47	0.68	0.00	0.45	0.11
Perineurial Cells, donor2	11579-120F4	12.15	9.94	1.10	0.09	0.00	0.18	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	48.77	20.08	1.27	0.64	2.23	0.96	1.27
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	35.02	17.63	7.84	5.14	1.22	1.96	3.18
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	47.11	24.46	6.86	3.24	1.55	1.94	0.91
Placental Epithelial Cells, donor1	11278-116H9	13.87	10.04	0.48	0.48	0.24	0.24	1.20
Placental Epithelial Cells, donor2	11355-117H5	17.74	14.42	2.22	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	17.47	12.96	3.14	1.57	0.20	0.79	0.79
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	8.23	1.27	2.85	1.27	0.00	0.63	0.00
Preadipocyte - breast, donor1	11467-119B9	6.19	2.06	0.38	0.56	0.19	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	19.84	8.88	0.52	0.26	0.39	0.26	0.00
Preadipocyte - breast, donor2	11328-117E5	7.20	3.15	1.35	1.13	0.00	0.68	0.00
Preadipocyte - omental, donor1	11468-119C1	8.74	2.45	1.07	0.43	0.00	0.53	0.00
Preadipocyte - omental, donor2	11329-117E6	5.24	3.06	0.44	0.44	0.00	0.00	0.44
Preadipocyte - omental, donor3	11403-118D8	10.46	5.73	1.00	1.00	0.29	0.43	0.00
Preadipocyte - perirenal, donor1	11469-119C2	4.92	1.97	0.98	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	14.43	9.83	0.61	0.31	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	16.47	5.14	3.36	1.59	0.18	1.42	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	11.24	3.41	1.36	0.34	0.00	0.00	0.00
Preadipocyte - visceral, donor1	11280-116I2	13.13	4.56	0.93	0.65	0.19	0.28	0.00
Preadipocyte - visceral, donor2	11357-117H7	11.96	4.60	4.14	1.84	0.00	0.92	0.00
Preadipocyte - visceral, donor3	11429-118G7	9.61	4.70	2.09	1.15	0.21	0.10	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	12.97	6.18	2.11	0.75	0.60	0.30	0.00
Prostate Epithelial Cells, donor2	11331-117E8	6.77	4.60	2.57	1.35	0.00	0.81	0.00
Prostate Epithelial Cells, donor3	11404-118D9	12.43	6.80	2.02	1.53	0.06	0.43	0.00
Prostate Stromal Cells, donor1	11254-116F3	10.14	6.49	1.37	1.14	0.00	0.34	0.00
Prostate Stromal Cells, donor2	11332-117E9	9.32	6.28	2.69	1.43	0.00	1.79	0.00
Prostate Stromal Cells, donor3	11405-118E1	9.59	5.11	3.02	1.36	0.10	0.52	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	15.33	9.12	0.00	0.00	0.00	0.00	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	9.36	4.37	0.76	0.69	0.21	0.07	0.14
Renal Epithelial Cells, donor1	11517-119H5	38.55	7.61	1.01	0.00	0.51	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	7.82	7.82	1.42	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	12.60	3.71	0.95	0.74	0.11	0.32	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	14.98	13.62	2.04	0.68	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	12.80	9.16	1.89	1.21	0.27	0.67	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	9.77	5.77	2.22	0.89	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	24.62	22.63	2.00	1.33	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	14.75	10.34	0.22	0.44	0.00	0.44	0.00
Renal Mesangial Cells, donor2	11598-120H5	22.57	6.27	1.25	1.25	0.00	0.63	0.63
Renal Mesangial Cells, donor3	11679-122H5	14.98	5.55	1.39	0.83	0.28	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	21.74	4.29	0.81	0.54	0.00	0.54	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	15.60	2.95	0.84	0.42	0.00	0.84	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	18.90	5.40	1.74	1.35	0.19	0.58	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	14.26	3.11	1.04	0.00	0.00	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	17.34	6.82	1.99	1.71	0.28	0.57	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	19.55	3.09	3.09	1.03	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	10.54	5.52	1.00	0.50	0.00	0.25	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	43.57	16.57	2.41	1.74	2.27	0.80	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	33.06	7.15	3.57	0.00	0.89	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	34.12	3.85	27.52	6.05	0.00	3.30	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	44.66	7.54	8.12	5.22	0.58	1.16	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	53.31	13.26	4.42	2.60	0.00	0.91	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	44.19	12.41	7.94	4.37	0.40	2.48	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	45.84	9.70	1.23	1.67	0.22	0.78	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	47.14	10.42	7.57	3.35	0.50	1.61	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	48.13	12.47	10.37	6.18	0.70	2.80	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	58.94	13.17	12.25	12.94	0.23	3.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	51.75	11.23	7.39	1.78	0.41	0.68	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	47.20	10.59	10.29	7.87	0.76	1.97	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	34.05	9.32	0.72	0.18	0.36	0.18	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	46.19	8.61	5.74	3.16	0.72	0.86	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	46.90	10.09	9.23	3.43	0.97	1.61	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	49.56	6.42	5.75	3.10	0.22	1.11	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	50.47	8.60	3.63	2.68	0.76	0.96	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	45.37	10.43	6.61	2.89	0.19	1.12	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	56.37	10.90	3.19	1.88	0.00	0.94	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	49.77	11.81	2.65	1.59	0.13	1.19	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	43.41	12.07	11.10	4.28	0.49	1.27	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	48.69	9.93	8.21	4.58	0.76	1.72	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	42.18	10.36	3.20	2.24	0.21	1.07	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	42.33	9.81	11.21	4.77	0.56	1.96	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	45.80	10.25	5.81	3.93	0.17	1.03	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	33.91	6.38	4.56	1.09	0.91	0.18	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	45.50	9.32	8.58	4.29	0.74	1.72	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	45.40	10.21	9.00	4.16	0.54	1.34	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	46.23	7.78	6.60	2.59	0.71	1.65	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	40.28	7.94	8.13	3.97	0.40	0.79	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	47.94	10.99	5.14	3.27	0.23	2.57	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	40.85	8.71	4.35	1.66	0.62	0.21	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	30.75	9.07	15.71	7.96	0.00	2.65	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	46.16	9.40	6.48	2.09	0.84	1.04	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	51.82	10.09	5.65	1.88	1.08	0.81	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	39.85	8.34	4.43	2.72	0.51	0.85	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	49.74	11.37	7.52	2.70	1.35	1.16	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	48.49	10.49	6.88	4.13	0.86	1.03	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	40.33	10.15	3.84	2.19	0.14	0.41	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	44.16	11.00	11.16	7.88	0.49	1.97	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	50.62	7.33	7.16	3.24	0.85	1.19	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	44.83	11.39	6.95	3.99	0.00	1.48	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	59.44	13.06	4.80	2.93	1.60	0.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	73.28	12.58	7.19	3.59	0.41	1.80	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	41.91	6.90	6.19	2.86	0.48	0.95	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	89.28	15.12	6.05	4.23	1.01	1.21	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	59.24	9.70	5.65	3.30	0.57	1.70	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	70.57	16.07	11.18	6.64	0.00	3.84	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	66.79	15.41	6.04	3.02	0.00	1.21	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	53.24	8.32	5.87	4.28	0.37	1.47	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	175.54	28.24	7.71	4.80	0.29	3.06	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	61.45	11.56	7.30	3.04	0.00	1.22	1.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	38.58	9.04	6.33	1.21	0.90	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	59.49	12.89	9.50	8.82	0.00	2.04	1.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	85.97	13.78	10.48	6.59	0.00	2.70	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	59.98	10.63	7.32	4.84	0.59	1.65	1.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	61.47	11.10	2.99	4.06	0.00	1.07	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	58.29	12.02	1.80	2.40	0.00	1.20	0.60
Schwann Cells, donor1	11498-119F4	15.42	5.83	2.26	1.32	0.00	0.00	0.19
Schwann Cells, donor2	11578-120F3	13.61	0.00	13.61	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	11.17	4.60	1.53	0.66	0.00	0.66	0.44
Sebocyte, donor1	11220-116B5	27.94	23.55	2.19	1.10	0.55	0.55	0.00
Sebocyte, donor2	11301-117B5	9.19	8.73	3.22	1.84	0.00	1.84	0.00
Sebocyte, donor3	11378-118B1	16.49	9.07	2.89	2.47	0.00	0.82	0.21
Sertoli Cells, donor1	11255-116F4	18.22	0.00	1.66	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	8.47	2.82	5.65	2.82	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	20.32	5.28	0.88	0.97	0.35	0.09	0.35
Skeletal Muscle Cells, donor2	11358-117H8	11.57	5.78	2.17	2.17	0.00	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	25.92	10.87	2.51	1.67	0.00	0.00	1.67
Skeletal Muscle Cells, donor4	11451-119A2	10.84	2.98	2.20	1.10	0.00	0.16	0.47
Skeletal Muscle Cells, donor5	11455-119A6	10.41	4.46	2.68	1.34	0.30	0.30	0.30
Skeletal Muscle Cells, donor6	11459-119B1	12.62	3.54	1.69	0.46	0.31	0.00	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	15.62	7.69	1.13	1.01	0.00	0.50	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	11.70	4.71	2.43	0.86	0.00	0.71	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	14.48	5.26	1.98	1.49	0.10	0.20	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	12.55	7.16	0.67	0.42	0.25	0.08	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	18.09	5.07	0.72	0.72	0.00	0.00	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	9.77	4.13	0.41	0.14	0.00	0.28	0.14
Skin - palm, donor1	10286-104F7	42.98	5.37	2.69	0.00	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	3.17	2.88	0.72	0.00	0.14	0.14	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	24.54	13.09	4.09	2.45	0.00	1.64	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	6.10	3.25	1.04	1.43	0.00	0.26	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	9.17	4.03	1.25	1.11	0.00	0.00	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	10.97	7.88	1.69	0.70	0.00	0.56	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	32.14	15.01	1.69	1.48	0.00	0.42	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	23.46	9.67	3.67	2.32	0.15	0.90	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	11.11	2.47	2.16	2.16	0.00	1.85	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	11.34	4.00	1.78	0.44	0.22	0.44	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	17.63	4.11	0.59	0.00	0.59	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	19.23	4.86	0.44	0.22	0.00	0.22	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	11.42	5.51	0.00	0.79	0.00	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	17.77	3.86	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	16.01	7.01	1.00	3.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	10.38	4.26	0.27	0.40	0.27	0.13	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	8.87	2.88	2.44	1.33	0.00	0.22	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	1.41	0.38	0.13	0.00	0.00	0.00	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	6.51	5.21	0.00	0.00	0.33	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	11.22	4.13	0.30	0.59	0.00	0.00	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	5.69	7.69	1.00	0.14	0.00	0.14	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	16.92	4.88	1.30	0.00	0.00	0.16	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	10.96	5.48	2.44	1.83	0.00	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	16.92	4.29	0.51	0.51	0.00	0.76	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	61.21	6.12	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	14.78	6.20	0.48	0.48	0.00	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	6.93	4.87	0.59	0.59	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	10.12	4.95	2.37	2.15	0.00	0.86	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	10.92	5.88	2.10	0.84	0.10	0.42	0.52
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	11.45	5.88	0.00	0.31	0.00	0.00	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	5.39	9.70	0.00	0.00	0.00	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	10.76	2.99	0.60	0.30	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	24.24	8.53	0.34	1.71	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	20.89	8.01	2.20	0.63	0.08	0.31	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	10.67	2.72	0.70	1.01	0.00	0.30	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	11.38	4.78	2.96	2.73	0.00	0.23	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	11.47	3.62	1.21	0.60	0.00	0.00	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	14.84	4.77	1.59	0.79	0.00	0.00	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	15.31	6.79	0.67	1.07	0.00	0.13	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	10.02	7.26	3.51	1.63	0.13	0.88	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	5.33	3.04	0.76	0.00	0.00	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	8.90	4.82	0.45	0.00	0.15	0.00	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	15.75	6.00	0.75	0.75	0.00	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	85.29	9.05	0.00	0.00	0.00	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	13.49	5.12	0.93	0.00	0.00	0.47	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	14.14	3.03	2.02	1.51	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	6.58	1.25	0.94	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	8.26	5.31	2.36	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	11.25	4.25	0.33	0.17	0.00	0.17	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	8.88	7.94	0.93	0.93	0.00	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	10.07	3.89	0.29	0.14	0.00	0.00	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	13.26	5.86	1.27	0.00	0.00	0.00	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	12.79	2.26	0.94	0.19	0.00	0.75	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	16.07	4.05	0.84	0.14	0.14	0.14	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	9.80	3.27	0.59	0.00	0.17	0.17	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	21.43	4.76	1.90	0.95	0.00	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	10.28	5.87	0.00	0.24	0.00	0.24	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	7.95	2.43	0.44	0.66	0.00	0.22	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	11.12	4.97	0.29	0.29	0.00	0.00	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	8.75	3.89	2.53	1.55	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	4.76	3.70	2.12	1.85	0.00	0.26	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	2.60	0.37	2.98	0.74	0.00	0.74	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	4.31	1.08	1.44	1.08	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	6.25	2.27	0.85	0.85	0.28	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	8.27	1.97	3.15	0.79	0.00	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	7.11	1.27	4.32	1.78	0.00	0.76	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	8.79	3.19	1.60	1.60	0.00	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	7.11	5.43	0.42	1.25	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	7.33	5.96	0.00	0.92	0.00	0.46	0.46
Synoviocyte, donor1	11291-117A4	10.44	2.19	1.18	0.84	0.00	0.34	0.00
Synoviocyte, donor2	11368-117I9	11.57	2.68	1.17	1.68	0.00	0.17	0.50
Synoviocyte, donor3	11440-118H9	9.38	4.69	1.79	2.01	0.00	0.67	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	25.37	10.72	0.36	1.79	0.00	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	19.82	3.96	1.98	0.00	0.00	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	25.93	9.96	2.55	1.85	0.23	2.08	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	13.48	5.66	0.36	0.29	0.07	0.14	0.22
Tracheal Epithelial Cells, donor2	11369-118A1	17.01	3.48	1.16	1.55	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	14.32	6.87	1.15	0.57	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	45.89	17.96	2.46	1.48	2.71	0.62	0.86
Urethra, donor2	10319-105A4	30.57	25.18	1.80	3.60	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	9.56	5.31	1.86	0.27	0.00	0.53	0.00
Urothelial Cells, donor2	11600-120H7	9.61	5.21	2.00	0.40	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	13.52	5.73	1.38	0.46	0.00	0.23	0.00
Urothelial cells, donor0	11216-116B1	13.60	4.46	0.89	0.22	0.00	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	67.62	44.49	8.01	5.34	0.89	1.78	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	55.75	55.75	5.72	0.00	2.86	1.43	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	49.29	58.87	26.70	10.95	3.42	7.53	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	45.11	39.25	4.48	3.10	2.41	2.75	1.38
Whole blood (ribopure), donor090325, donation2	12177-128I8	42.42	35.44	4.07	2.91	1.16	0.58	2.91
Whole blood (ribopure), donor090612, donation1	12182-129A4	67.68	66.64	8.33	2.08	8.33	1.04	2.08
Whole blood (ribopure), donor090612, donation2	12183-129A5	64.25	53.23	3.67	0.92	3.67	2.75	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	48.38	39.25	21.91	10.95	1.83	4.56	1.83
Wilms' tumor cell line:G-401	10809-111A8	8.76	4.32	1.23	0.49	0.12	0.00	0.12
Wilms' tumor cell line:HFWT	10597-108E3	7.04	8.80	0.88	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	13.41	13.13	1.68	0.84	0.28	0.56	0.00
achilles tendon, donor2	10292-104G4	24.80	8.27	0.00	2.07	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	18.61	4.84	1.27	1.53	0.51	0.76	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	25.54	6.27	0.46	0.46	0.23	0.70	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	50.45	17.57	1.31	1.78	1.19	0.47	0.71
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	20.68	5.99	2.18	0.27	0.27	0.27	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	6.46	6.18	1.12	1.41	0.00	0.28	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	12.69	7.19	0.85	0.42	0.21	0.21	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	40.29	16.88	5.99	2.72	0.00	2.18	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	13.66	14.54	3.08	0.88	0.88	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	24.09	9.39	4.49	2.04	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	22.91	14.76	1.55	0.78	0.00	0.78	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	13.62	4.42	2.39	2.02	0.37	1.29	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	54.61	27.30	0.00	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	25.33	9.53	4.18	1.86	0.23	0.46	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	20.19	14.50	4.92	2.59	0.00	1.29	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	21.04	13.44	5.55	2.63	0.29	1.17	1.46
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	30.21	20.45	4.18	2.79	0.00	1.86	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	17.68	4.11	3.29	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	15.65	19.03	0.92	0.61	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	34.56	23.47	3.84	2.56	0.00	0.00	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	25.78	20.02	2.12	0.91	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	32.74	19.02	2.65	2.17	0.00	0.72	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	16.26	5.79	1.78	1.56	0.22	0.89	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	24.35	7.00	1.67	2.00	0.00	0.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	26.01	26.01	1.86	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	25.99	17.33	2.26	3.39	0.00	0.38	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	41.00	36.64	8.72	2.62	1.74	1.31	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	28.12	33.74	1.87	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	20.49	4.47	0.24	0.24	0.94	0.24	0.00
adipose tissue, adult, pool1	10010-101C1	25.13	9.93	1.86	1.40	0.78	0.31	0.78
adipose, donor1	10184-103D4	17.59	5.86	8.80	7.04	0.00	1.17	0.00
adipose, donor2	10185-103D5	7.70	10.14	0.41	0.41	0.00	0.00	0.00
adipose, donor3	10186-103D6	20.97	16.07	3.00	1.36	0.82	0.00	0.00
adipose, donor4	10187-103D7	43.34	14.73	3.47	2.60	0.87	2.60	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	16.89	20.52	1.26	0.32	0.63	0.47	0.16
adrenal gland, adult, pool1	10081-102A9	29.10	14.55	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	28.82	6.00	0.80	0.13	1.60	0.13	0.80
alveolar cell carcinoma cell line:SW 1573	10708-109H6	26.80	12.86	3.93	1.43	0.00	0.36	0.71
amniotic membrane cells, donor1	12235-129G3	11.82	5.56	0.46	0.70	1.16	0.00	0.70
amniotic membrane cells, donor2	12236-129G4	18.93	8.45	0.68	0.34	0.68	0.34	0.34
amniotic membrane cells, donor3	12237-129G5	9.43	7.37	1.77	0.29	1.47	0.29	0.29
amygdala - adult, donor10196	10167-103B5	14.23	5.93	2.37	1.19	0.00	1.19	0.00
amygdala, adult, donor10252	10151-102I7	29.81	20.48	6.08	2.23	2.84	0.61	1.01
amygdala, newborn, donor10223	10360-105E9	9.36	4.20	1.61	0.97	0.00	0.32	1.29
anaplastic carcinoma cell line:8305C	10428-106D5	29.29	5.35	0.76	1.15	0.25	0.89	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	20.96	10.37	0.88	0.88	0.22	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	36.41	16.70	1.00	1.67	2.34	1.00	0.00
aorta, adult, pool1	10052-101G7	27.65	9.81	4.31	2.55	0.78	1.18	0.98
appendix, adult	10189-103D9	45.41	20.18	8.54	2.33	1.94	0.00	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	32.33	18.57	1.72	0.34	3.10	1.38	0.34
artery, adult	10190-103E1	25.82	8.15	9.51	8.15	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	27.24	7.97	0.87	0.43	0.14	0.00	0.00
b cell line:RPMI1788	10427-106D4	23.94	9.22	0.45	1.19	1.19	0.74	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	9.71	3.05	1.11	1.39	0.28	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	21.33	9.63	0.99	0.89	0.30	0.20	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	24.27	3.35	2.01	0.84	0.33	0.17	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	29.08	11.18	2.24	1.12	0.00	0.00	0.56
bladder, adult, pool1	10011-101C2	28.03	15.75	2.82	1.41	0.65	0.43	0.11
blood, adult, pool1	10053-101G8	19.93	13.29	13.29	0.00	2.21	2.21	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	18.84	3.43	0.00	0.00	0.86	0.00	0.00
bone marrow, adult	10192-103E3	19.57	16.87	16.20	10.80	0.67	2.70	0.67
brain, adult, donor1	10084-102B3	10.25	5.13	3.08	2.05	2.05	1.03	0.00
brain, adult, pool1	10012-101C3	11.25	8.80	1.34	0.33	1.45	0.11	0.00
brain, fetal, pool1	10085-102B4	10.69	13.36	2.67	0.00	0.00	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	24.78	37.99	3.96	3.96	0.99	0.99	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	53.42	32.70	3.37	1.00	7.61	0.50	0.12
breast, adult, donor1	10080-102A8	17.68	14.52	1.26	0.63	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	28.71	19.18	3.56	3.56	0.89	1.14	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	26.90	6.49	0.93	2.47	0.31	0.31	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	6.68	3.22	5.06	2.53	0.23	0.92	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	16.22	3.87	0.48	1.69	0.73	0.48	0.00
carcinoid cell line:NCI-H1770	10703-109H1	19.28	1.41	1.41	1.88	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	57.21	26.69	7.22	3.06	0.22	0.88	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	28.84	5.07	1.90	1.27	0.00	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	39.39	33.01	13.04	5.06	1.33	3.73	0.00
caudate nucleus - adult, donor10196	10177-103C6	26.48	11.51	5.76	1.15	5.76	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	29.62	12.38	4.52	3.51	2.01	0.84	0.50
caudate nucleus, adult, donor10258	10379-105H1	19.10	5.35	4.58	2.29	0.76	3.06	0.00
caudate nucleus, newborn, donor10223	10354-105E3	13.18	7.69	4.39	1.10	0.37	0.37	1.83
cerebellum - adult, donor10196	10173-103C2	40.79	17.48	8.74	5.83	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	73.23	15.59	10.25	6.83	5.55	2.56	1.07
cerebellum, adult, pool1	10083-102B2	20.35	6.21	3.10	1.03	0.69	0.34	0.69
cerebellum, newborn, donor10223	10357-105E6	21.59	13.28	5.81	5.81	1.66	2.49	2.49
cerebral meninges, adult	10188-103D8	9.58	5.55	0.50	0.76	1.01	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	16.08	6.58	1.46	0.73	1.46	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	22.86	13.52	1.73	1.15	0.00	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	36.29	20.22	1.99	1.66	0.50	0.83	0.00
cervix, adult, pool1	10013-101C4	46.93	24.15	1.89	1.89	0.84	0.52	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	13.10	6.97	1.11	0.14	0.28	0.42	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	7.84	13.06	0.00	1.31	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	34.18	12.30	2.98	2.73	0.12	1.24	0.12
choriocarcinoma cell line:SCH	10785-110H2	25.14	29.08	2.09	1.60	1.36	1.36	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	23.01	7.59	0.71	0.00	0.24	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	9.40	7.41	1.14	0.28	0.57	0.28	0.85
chorionic membrane cells, donor2	12239-129G7	12.73	7.56	1.59	0.99	0.10	0.40	0.00
chorionic membrane cells, donor3	12240-129G8	15.39	7.14	4.95	2.75	1.10	1.65	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	10.10	5.05	4.04	1.01	0.00	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	16.14	8.64	0.96	0.58	0.19	0.00	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	16.68	11.40	0.84	0.84	0.00	0.21	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	17.21	6.16	2.31	1.03	0.00	0.26	1.03
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	26.12	8.71	3.14	1.69	0.00	0.24	1.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	18.73	6.92	3.46	1.83	0.20	0.81	0.81
chronic myelogenous leukemia cell line:K562	10454-106G4	17.08	7.36	0.59	0.59	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	22.67	14.86	1.30	0.26	0.00	0.26	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	14.86	5.26	4.11	2.51	0.00	1.14	0.23
clear cell carcinoma cell line:TEN	10636-108I6	29.15	7.81	2.78	1.21	0.17	0.17	0.00
colon carcinoma cell line:CACO-2	10513-107D9	18.49	11.71	0.55	1.28	0.55	0.18	0.00
colon carcinoma cell line:COLO-320	10420-106C6	122.77	34.59	8.74	2.28	1.14	1.52	0.00
colon, adult, donor1	10082-102B1	38.08	11.90	2.38	2.38	1.19	0.00	1.19
colon, adult, pool1	10014-101C5	50.64	12.22	0.59	1.53	3.64	0.12	0.24
colon, fetal, donor1	10070-101I7	37.08	6.80	4.94	0.62	5.56	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	68.75	87.09	0.00	0.00	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	42.92	4.25	1.70	0.85	0.00	0.00	3.40
cord blood derived cell line:COBL-a 24h infection	10453-106G3	30.49	2.26	1.66	1.36	0.00	0.00	0.75
cord blood derived cell line:COBL-a untreated	10449-106F8	29.89	4.09	0.56	0.85	0.14	0.28	0.85
corpus callosum, adult, pool1	10042-101F6	39.69	27.09	2.32	1.11	5.53	0.44	0.44
cruciate ligament, donor2	10295-104G7	34.04	15.40	0.00	0.81	1.62	0.00	1.62
diaphragm, fetal, donor1	10069-101I6	16.05	12.84	1.61	1.61	0.00	0.00	0.00
diencephalon, adult	10193-103E4	14.64	6.48	0.96	1.68	0.96	0.24	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	20.44	10.79	7.81	3.21	0.23	1.61	0.69
ductal cell carcinoma cell line:KLM-1	10438-106E6	61.80	20.00	2.56	2.56	0.26	0.77	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	6.02	8.18	0.48	0.48	0.00	0.48	0.48
ductus deferens, adult	10196-103E7	83.72	13.95	12.46	8.97	1.00	2.49	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	25.92	17.28	2.88	2.88	2.88	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	47.82	15.45	13.24	5.15	2.94	2.94	0.00
dura mater, adult, donor1	10041-101F5	49.14	22.96	2.23	2.15	1.07	0.83	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	13.99	1.55	0.00	2.66	0.44	0.00	2.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	18.48	4.16	0.43	1.58	0.57	0.14	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	28.36	28.98	1.23	0.62	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	20.89	12.41	1.82	1.51	0.00	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	30.57	18.52	1.23	0.62	0.31	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	30.21	15.76	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	20.45	5.36	1.34	1.34	0.00	0.00	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	26.46	9.97	2.36	2.36	0.36	1.09	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	12.87	12.70	4.02	1.13	0.64	0.32	0.16
epidermoid carcinoma cell line:A431	10426-106D3	24.90	7.89	0.56	1.22	0.56	0.22	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	23.43	8.25	1.32	0.88	0.22	0.22	0.00
epididymis, adult	10197-103E8	49.19	12.98	4.81	5.65	1.05	0.63	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	17.03	10.11	1.42	1.95	0.18	0.89	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	23.20	11.80	1.57	1.97	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	24.64	5.77	6.16	3.67	0.66	1.57	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	42.32	11.22	8.96	2.76	0.49	2.56	0.30
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	24.31	7.17	5.04	1.90	1.01	1.34	0.34
esophagus, adult, pool1	10015-101C6	29.94	10.94	2.65	1.17	1.17	0.64	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	18.91	39.70	3.13	1.75	0.00	0.50	0.00
eye - muscle inferior rectus, donor1	10272-104E2	65.19	12.07	2.41	0.00	2.41	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	21.04	4.21	0.00	0.00	0.00	0.00	2.10
eye - muscle medial, donor2	10299-104H2	22.32	5.95	1.49	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	30.96	11.46	0.00	1.15	0.00	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	42.26	18.95	0.00	1.46	0.00	1.46	0.00
eye, fetal, donor1	10054-101G9	34.83	18.05	9.66	4.83	1.78	1.53	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	16.03	5.77	0.77	0.77	0.13	0.13	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	12.58	8.78	0.71	0.47	0.24	0.47	0.00
frontal lobe, adult, pool1	10040-101F4	21.11	8.91	1.03	0.66	2.44	0.00	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	28.82	14.71	3.60	1.20	2.70	1.50	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	30.54	9.51	2.01	0.64	0.09	0.27	0.00
gall bladder, adult	10198-103E9	46.36	18.59	6.04	2.41	1.21	0.97	0.00
gamma delta positive T cells, donor1	11937-126A2	24.16	9.13	1.07	0.00	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	24.65	5.98	2.99	0.00	0.37	0.00	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	29.78	16.47	6.76	4.22	0.63	1.27	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	43.91	31.33	2.32	1.55	0.00	0.77	0.39
gastric cancer cell line:AZ521	10549-107H9	52.79	28.20	1.64	0.98	0.49	0.49	0.00
gastric cancer cell line:GSS	10560-108A2	41.19	12.81	3.66	0.00	0.00	1.83	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	54.14	30.84	19.19	7.54	1.14	3.88	0.91
giant cell carcinoma cell line:LU65	10487-107B1	12.05	2.98	1.38	0.34	0.00	0.23	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	21.13	11.48	0.84	0.28	0.28	0.00	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	61.36	19.95	3.49	5.24	0.25	1.25	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	17.94	7.60	0.95	0.53	0.32	0.21	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	16.85	8.15	0.84	0.84	0.28	0.00	0.00
glioblastoma cell line:T98G	10485-107A8	13.80	4.75	1.10	0.66	0.00	0.00	0.00
glioma cell line:GI-1	10413-106B8	26.36	11.72	1.46	1.17	0.00	0.29	0.00
globus pallidus - adult, donor10196	10175-103C4	10.20	8.75	0.00	0.00	2.19	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	44.18	33.20	6.83	3.42	4.15	2.44	0.73
globus pallidus, adult, donor10258	10367-105F7	10.95	10.95	0.00	1.37	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	12.26	7.99	1.07	0.53	0.53	1.07	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	129.70	68.52	0.00	0.00	0.00	0.00	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	5.23	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	13.76	5.76	1.92	1.28	0.00	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	10.56	5.51	3.21	0.92	0.46	0.00	0.46
hIPS +CCl2, biol_rep2	14384-156C1	7.32	4.57	0.46	0.91	0.00	1.37	0.46
hIPS +CCl2, biol_rep3	14385-156C2	9.66	4.51	0.00	0.64	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	2.87	2.87	1.44	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	5.49	5.49	1.37	1.37	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	15.45	5.52	3.31	2.21	4.41	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	16.09	10.06	1.72	0.29	0.57	0.86	0.86
heart - mitral valve, adult	10205-103F7	30.49	7.77	3.59	0.90	1.20	0.30	0.00
heart - pulmonic valve, adult	10206-103F8	34.51	14.64	7.06	5.75	2.09	2.35	0.00
heart - tricuspid valve, adult	10207-103F9	26.64	12.49	3.33	0.83	0.83	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	27.55	18.37	9.59	5.71	1.02	2.86	0.20
heart, adult, diseased, donor1	10051-101G6	29.81	3.83	2.98	2.13	0.00	1.28	0.00
heart, adult, pool1	10016-101C7	24.15	9.20	0.00	0.00	0.46	0.00	0.23
heart, fetal, pool1	10046-101G1	45.49	17.04	1.85	0.62	1.23	0.31	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	11.72	4.01	0.00	0.31	0.00	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	26.16	26.16	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	23.09	14.14	5.86	1.99	0.66	1.10	0.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	24.76	12.74	7.40	2.67	0.36	1.09	0.36
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	32.13	18.49	6.06	2.12	0.81	1.21	0.20
hepatoma cell line:Li-7	10484-107A7	24.13	7.45	1.33	1.22	0.11	0.33	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	12.56	6.63	0.60	0.50	0.40	0.10	0.40
hippocampus - adult, donor10196	10169-103B7	15.14	8.52	2.84	1.89	1.89	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	36.33	20.00	7.76	2.65	3.47	3.67	1.02
hippocampus, adult, donor10258	10374-105G5	9.46	3.49	1.00	1.00	1.49	1.00	0.00
hippocampus, newborn, donor10223	10363-105F3	7.05	4.58	3.17	0.70	0.00	0.35	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	3.05	6.10	3.66	3.05	0.61	1.22	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	11.58	5.30	2.16	1.18	0.20	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	12.19	6.35	4.32	1.78	1.27	0.00	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	23.68	3.38	2.82	2.82	1.69	1.69	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	24.79	8.00	13.69	4.13	0.77	3.36	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	24.67	6.07	3.04	3.80	0.38	0.76	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	21.02	19.27	3.50	2.63	1.75	1.46	1.17
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	20.25	19.82	5.17	1.94	0.65	1.51	1.08
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	32.95	25.44	0.83	0.83	0.00	0.83	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	15.87	9.47	0.71	0.71	0.71	0.24	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	15.91	13.82	4.66	3.38	0.64	1.13	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	17.51	15.49	0.67	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	11.42	6.89	2.97	1.72	1.41	0.63	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	9.33	1.97	7.86	0.98	0.49	0.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	5.24	2.62	6.11	2.62	0.00	2.62	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	30.55	11.26	4.77	3.05	0.38	1.53	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	27.47	12.65	4.80	2.62	0.00	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	20.99	7.00	7.00	1.50	0.50	0.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	12.06	15.07	2.64	1.13	0.19	0.75	0.75
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	14.10	14.10	3.18	2.73	0.91	0.45	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	11.90	14.41	2.82	0.94	0.00	0.63	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	8.49	9.31	3.10	1.80	0.00	0.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	12.77	13.64	2.03	1.74	0.29	0.00	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	12.26	12.55	2.99	1.49	0.30	1.79	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	9.61	5.73	3.69	1.66	0.92	0.18	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	13.98	5.99	0.86	1.14	0.57	0.29	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	11.84	4.49	5.31	1.63	1.63	0.00	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	20.42	13.03	9.86	2.46	0.00	2.11	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	17.10	7.92	1.90	2.22	0.63	1.27	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	15.74	10.29	2.72	1.51	0.30	1.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	20.17	16.55	1.55	2.07	0.52	0.52	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	13.28	19.92	3.32	1.99	0.00	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	16.42	17.19	1.54	1.28	1.28	0.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	15.59	14.57	10.23	2.81	0.51	1.53	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	25.75	25.75	2.27	1.51	1.51	3.79	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	9.07	7.39	2.69	1.34	0.00	0.34	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	14.97	4.83	2.90	0.72	0.97	0.24	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	9.36	4.01	3.12	3.12	1.34	0.89	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	12.68	7.32	4.39	1.46	1.95	1.46	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	26.89	11.61	5.81	2.14	0.92	0.31	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	13.01	6.51	35.79	9.76	3.25	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	18.20	5.96	7.94	4.30	0.66	1.65	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	22.99	27.91	5.47	0.55	1.09	1.09	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	16.28	20.63	3.26	1.81	1.09	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	18.51	19.57	3.91	1.78	0.36	1.42	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	14.32	8.35	2.39	3.58	1.19	2.39	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	23.02	17.61	4.33	2.44	1.35	0.81	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	12.66	8.08	4.31	2.42	0.81	0.27	0.27
immature langerhans cells, donor1	11904-125F5	12.59	3.87	0.00	0.24	0.48	0.00	0.00
immature langerhans cells, donor2	11905-125F6	18.22	5.54	0.79	1.58	0.79	0.79	1.58
insula, adult, pool1	10039-101F3	25.83	12.21	1.32	0.47	1.70	0.38	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	22.11	11.06	0.65	0.98	0.65	0.33	0.00
kidney, adult, pool1	10017-101C8	26.63	8.91	1.60	1.10	0.10	0.80	0.30
kidney, fetal, pool1	10045-101F9	47.32	22.71	2.83	1.70	1.56	0.50	0.50
large cell lung carcinoma cell line:IA-LM	10509-107D5	35.51	23.15	0.71	1.14	0.00	0.57	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	16.45	6.36	3.04	1.24	0.28	0.28	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	20.18	13.58	0.92	0.92	0.00	0.18	0.00
left atrium, adult, donor1	10079-102A7	14.71	7.08	2.72	1.63	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	9.61	3.54	0.51	1.52	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	9.03	5.47	0.27	0.55	0.55	0.00	1.09
leiomyoma cell line:10964C	10569-108B2	2.87	5.03	1.80	1.80	0.00	0.00	0.36
leiomyoma cell line:15242A	10570-108B3	5.43	1.09	0.00	0.54	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	5.58	2.43	2.19	1.46	0.00	0.49	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	19.87	18.82	3.14	2.09	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	25.50	11.10	0.94	1.18	0.00	0.12	0.59
liposarcoma cell line:KMLS-1	10782-110G8	11.87	4.69	1.72	0.16	0.00	0.16	0.00
liposarcoma cell line:SW 872	10726-110A6	19.25	6.21	1.10	0.85	0.12	0.00	0.12
liver, adult, pool1	10018-101C9	18.80	7.94	1.30	1.13	0.65	0.16	0.16
liver, fetal, pool1	10086-102B5	12.23	7.53	1.88	0.94	0.94	1.88	0.00
locus coeruleus - adult, donor10196	10182-103D2	10.50	9.92	2.48	0.44	1.75	0.29	0.15
locus coeruleus, adult, donor10252	10165-103B3	23.25	18.46	6.09	3.51	1.29	1.29	0.74
locus coeruleus, adult, donor10258	10375-105G6	10.44	8.46	3.10	1.41	2.26	1.41	0.00
locus coeruleus, newborn, donor10223	10362-105F2	9.67	7.15	4.63	2.10	0.00	1.26	1.26
lung adenocarcinoma cell line:A549	10499-107C4	31.83	8.58	0.55	0.28	0.00	0.00	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	25.51	14.48	1.38	0.00	0.69	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	30.05	10.02	3.43	1.45	0.13	0.79	0.00
lung, adult, pool1	10019-101D1	21.26	16.89	1.06	1.42	0.71	0.00	0.35
lung, fetal, donor1	10068-101I5	78.20	33.11	2.28	3.71	7.99	1.14	1.43
lung, right lower lobe, adult, donor1	10075-102A3	24.74	13.75	5.50	6.87	0.92	0.46	0.00
lymph node, adult, donor1	10077-102A5	13.73	12.78	1.89	0.95	0.00	0.95	0.00
lymphangiectasia cell line:DS-1	10727-110A7	16.22	12.49	2.63	0.88	1.10	0.66	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	31.54	3.32	1.51	1.06	0.45	0.75	1.21
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	51.82	29.73	1.70	3.40	0.00	0.85	0.00
mature adipocyte, donor1	12231-129F8	33.30	6.22	0.00	0.00	0.89	0.00	0.44
mature adipocyte, donor2	12232-129F9	25.94	4.15	0.62	0.42	1.45	0.00	0.21
mature adipocyte, donor3	12233-129G1	25.13	3.08	0.47	0.00	0.00	0.24	0.71
mature adipocyte, donor4	12234-129G2	28.43	4.74	0.53	0.26	0.00	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	81.48	67.43	5.72	4.29	1.19	1.91	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	12.41	5.64	1.13	1.13	1.13	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	26.67	15.08	3.86	2.57	2.94	2.02	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	3.49	3.49	3.49	0.95	0.95	0.95	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	4.69	2.99	3.84	2.56	0.85	0.43	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	11.64	6.41	10.13	2.19	1.18	2.70	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	34.38	19.95	5.31	2.55	2.33	2.76	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	7.71	0.00	3.85	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	0.00	0.00	14.35	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	8.61	4.31	1.44	0.72	0.36	0.72	1.44
medulla oblongata - adult, donor10196	10174-103C3	9.09	5.84	1.30	0.65	0.65	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	34.21	17.80	5.88	3.10	3.41	1.55	0.93
medulla oblongata, adult, pool1	10038-101F2	26.45	16.41	1.14	0.73	3.35	0.73	0.24
medulla oblongata, newborn, donor10223	10361-105F1	18.05	12.85	2.08	1.74	0.35	1.39	0.00
medulloblastoma cell line:D283 Med	10838-111E1	79.49	54.25	18.38	12.84	1.55	3.99	0.89
medulloblastoma cell line:ONS-76	10759-110E3	13.21	8.44	0.24	0.61	0.12	0.24	0.12
melanoma cell line:COLO 679	10514-107E1	30.76	4.46	1.72	1.44	0.00	0.43	0.29
melanoma cell line:G-361	10465-106H6	24.43	5.70	1.90	0.81	0.27	0.54	0.27
meningioma cell line:HKBMM	10691-109F7	12.48	3.08	3.98	1.09	0.00	0.72	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	42.30	10.57	7.93	5.29	0.00	2.64	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	39.40	19.70	7.26	4.67	0.26	0.26	1.81
mesenchymal precursor cell - adipose, donor1	11747-123G1	13.50	4.91	1.38	0.92	0.15	0.46	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	14.72	5.64	3.82	0.55	0.00	0.18	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	7.45	1.66	0.41	1.66	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	13.35	2.95	1.26	0.84	0.14	0.56	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	12.52	2.12	2.31	0.96	0.00	0.19	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	13.88	2.78	0.69	2.08	0.00	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	10.81	4.29	1.37	0.86	0.00	0.51	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	14.26	4.14	1.84	1.27	0.00	0.58	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	11.01	5.84	2.12	0.53	0.00	0.13	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	9.72	3.92	1.89	1.08	0.00	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	10.95	3.84	2.13	1.00	0.14	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	14.16	7.25	1.32	0.66	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	13.01	3.74	1.25	0.83	0.00	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	15.01	3.84	0.70	1.75	0.00	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	6.33	2.65	0.82	1.02	0.00	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	9.71	2.52	0.72	0.36	0.00	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	8.69	4.24	1.55	1.03	0.21	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	7.30	2.51	1.60	1.14	0.23	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	4.20	4.20	2.10	1.68	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	9.12	3.74	1.49	0.00	0.15	0.15	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	13.39	4.64	2.54	1.40	0.00	0.53	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	12.89	4.05	1.47	0.00	0.00	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	8.58	4.29	1.43	0.29	0.00	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	10.53	2.95	2.95	2.95	0.00	0.42	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	6.39	2.74	0.46	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	6.14	2.56	1.02	0.51	0.00	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	6.81	2.36	0.79	1.05	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	12.02	4.01	0.92	0.62	0.31	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	6.12	3.77	2.59	1.18	0.00	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	11.51	5.08	1.02	0.34	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	8.25	3.93	1.57	0.39	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	4.17	1.85	0.93	0.46	0.00	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	7.50	3.75	2.31	0.58	0.00	0.58	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	8.03	4.91	0.89	0.45	0.22	0.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	9.37	1.92	1.20	0.48	0.00	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	8.07	4.40	2.93	0.00	0.00	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	5.03	3.36	1.68	0.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	6.55	5.32	1.23	0.41	0.00	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	7.30	2.58	0.43	1.72	0.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	10.94	2.73	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	0.00	5.16	0.00	0.00	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	4.22	1.62	0.32	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	5.82	1.45	1.45	0.00	0.00	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	5.33	3.73	0.53	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	7.36	1.64	0.82	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	5.05	1.17	1.17	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	2.10	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	2.98	1.99	0.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	6.52	1.19	0.59	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	6.09	4.87	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	5.70	3.80	0.00	0.00	0.00	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	5.17	1.72	0.34	0.34	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	4.30	8.60	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	3.44	3.44	0.00	0.00	0.00	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	8.96	1.63	1.63	0.41	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	8.74	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	6.48	1.18	0.59	0.00	1.18	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	4.68	1.87	0.31	0.00	0.00	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	8.02	6.68	1.34	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	4.73	1.18	1.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	5.14	0.00	0.00	2.57	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	9.64	2.07	1.38	0.69	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	10.89	3.46	0.49	0.49	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	10.09	1.12	2.24	0.00	1.12	1.12	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	3.82	1.27	0.64	0.64	0.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	4.84	1.61	0.81	0.81	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	8.72	2.18	4.36	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	8.87	1.27	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	10.32	4.25	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	9.04	4.52	9.04	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	9.06	4.94	1.65	0.00	0.00	0.82	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	5.36	1.79	0.79	0.20	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	3.89	1.95	0.00	0.00	0.00	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	7.13	1.02	2.04	2.04	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	19.34	15.47	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	14.41	11.81	1.42	0.24	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	21.31	6.49	0.70	0.23	1.39	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	8.55	0.00	4.27	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	5.34	1.34	0.62	1.03	0.00	0.10	0.10
mesothelioma cell line:Mero-25	10850-111F4	9.76	6.13	1.36	1.13	0.00	0.45	0.23
mesothelioma cell line:Mero-41	10851-111F5	18.58	3.67	0.98	1.71	0.24	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	8.19	4.21	1.11	1.11	0.22	0.44	0.00
mesothelioma cell line:Mero-82	10853-111F7	16.56	1.84	3.42	0.53	0.26	0.53	0.00
mesothelioma cell line:Mero-83	10854-111F8	9.70	3.23	1.36	0.51	0.17	0.85	0.00
mesothelioma cell line:Mero-84	10855-111F9	7.58	8.09	1.26	0.76	0.00	0.51	0.00
mesothelioma cell line:Mero-95	10856-111G1	11.18	8.90	0.83	0.83	0.00	0.00	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	11.93	5.14	0.50	0.99	0.00	0.00	0.00
mesothelioma cell line:NCI-H226	10846-111E9	11.76	7.24	1.63	1.09	0.00	0.72	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	14.52	6.49	1.71	1.71	0.00	0.51	0.34
mesothelioma cell line:NCI-H28	10845-111E8	25.19	5.85	4.33	2.54	0.00	0.76	0.00
mesothelioma cell line:No36	10857-111G2	7.83	4.89	0.98	0.33	0.00	0.65	0.33
mesothelioma cell line:ONE58	10858-111G3	14.90	2.71	1.35	0.27	0.00	0.54	0.27
migratory langerhans cells, donor1	11901-125F2	4.41	4.03	1.54	0.38	0.19	0.38	0.38
migratory langerhans cells, donor2	11902-125F3	9.77	3.30	0.73	0.49	0.24	0.37	0.00
migratory langerhans cells, donor3	11903-125F4	6.82	4.13	0.72	0.36	0.54	0.18	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	12.08	6.20	5.55	1.96	0.00	2.61	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	6.57	1.70	1.48	0.21	0.21	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	23.73	11.98	0.69	0.92	0.00	0.23	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	13.13	4.38	1.14	0.38	0.00	0.57	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	12.01	4.80	1.11	0.55	0.37	0.37	0.18
myeloma cell line:PCM6	10474-106I6	27.48	4.15	0.79	1.38	0.00	0.20	0.79
myxofibrosarcoma cell line:MFH-ino	10600-108E6	9.64	10.15	0.00	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	29.22	1.57	0.20	0.98	0.20	0.00	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	8.36	5.46	0.33	0.00	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	9.12	2.79	0.96	0.22	0.07	0.29	0.15
nasal epithelial cells, donor2	12227-129F4	19.87	9.38	1.10	0.55	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	60.05	21.40	2.99	0.69	0.69	0.69	0.69
neuroblastoma cell line:NB-1	10539-107G8	36.11	15.72	1.50	0.75	0.37	0.56	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	117.68	21.72	7.38	5.69	0.00	0.84	1.69
neuroblastoma cell line:NH-12	10555-107I6	47.71	20.31	0.93	1.12	0.93	0.75	0.56
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	48.39	22.54	12.57	5.93	0.47	3.56	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	73.81	22.97	13.46	7.44	0.32	3.17	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	14.29	10.26	0.81	0.20	0.20	0.20	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	61.67	20.98	1.27	0.64	0.64	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	7.98	7.45	0.27	0.27	0.00	0.00	0.00
neutrophil PMN, donor1	12133-128D9	297.50	267.75	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	26.56	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	28.41	28.41	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	38.73	7.27	1.52	1.35	0.17	0.00	1.18
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	18.41	7.20	0.00	0.00	1.60	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	7.69	6.73	0.96	1.28	0.00	0.32	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	7.62	4.47	2.89	1.84	0.00	0.53	0.00
nucleus accumbens, adult, pool1	10037-101F1	25.59	10.87	1.12	0.94	1.50	0.09	0.19
occipital cortex - adult, donor10196	10172-103C1	14.42	2.06	4.12	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	38.64	19.59	7.25	1.88	4.03	1.88	0.54
occipital cortex, newborn, donor10223	10355-105E4	8.37	6.55	1.46	0.73	0.36	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	12.07	6.04	1.84	2.10	0.00	0.00	0.00
occipital lobe, fetal, donor1	10073-102A1	14.16	6.87	5.15	1.29	1.29	0.86	0.00
occipital pole, adult, pool1	10036-101E9	17.03	7.17	0.47	0.16	1.02	0.00	0.00
olfactory region, adult	10195-103E6	16.43	12.04	4.39	0.57	1.91	0.76	0.19
optic nerve, donor1	10277-104E7	18.01	4.00	2.00	0.00	8.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	37.59	19.82	1.71	1.14	0.23	0.91	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	13.46	2.75	0.96	0.27	0.14	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	19.47	16.76	9.31	4.91	0.00	1.35	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	42.62	5.89	2.66	1.04	0.23	0.23	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	15.58	2.35	1.18	1.18	0.00	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	27.10	30.83	0.00	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	22.69	6.36	0.85	0.64	0.00	0.42	0.42
ovary, adult, pool1	10020-101D2	30.31	14.85	1.22	1.22	0.44	0.17	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	10.27	6.78	1.65	0.55	0.00	0.55	0.18
pancreas, adult, donor1	10049-101G4	23.52	10.35	3.76	5.64	3.76	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	15.65	10.34	0.56	1.12	0.00	0.28	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	15.50	4.09	4.77	3.07	0.17	1.02	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	29.64	6.62	1.99	0.50	0.00	0.17	0.17
paracentral gyrus, adult, pool1	10035-101E8	16.38	9.06	0.82	0.46	1.56	0.46	0.00
parietal cortex, adult, donor10258	10373-105G4	22.75	11.01	0.73	0.73	1.47	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	5.64	2.82	0.94	0.00	1.88	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	26.22	14.25	5.99	2.85	1.43	1.14	0.57
parietal lobe, adult, pool1	10034-101E7	18.86	9.69	0.70	0.18	2.20	0.35	0.00
parietal lobe, fetal, donor1	10072-101I9	14.55	5.82	7.76	2.91	0.00	1.94	0.00
parietal lobe, newborn, donor10223	10356-105E5	7.48	4.49	2.62	0.75	0.37	0.00	1.50
parotid gland, adult	10199-103F1	35.77	9.25	4.93	1.85	3.08	2.47	0.00
penis, adult	10200-103F2	24.17	9.13	7.52	4.30	1.07	1.07	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	54.29	37.19	13.20	7.44	0.93	1.86	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	34.24	28.85	2.62	1.60	1.75	1.17	0.00
pineal gland - adult, donor10196	10179-103C8	104.49	10.97	6.45	1.29	3.23	1.29	0.00
pineal gland, adult, donor10252	10160-103A7	200.76	24.28	10.66	10.07	8.29	2.37	0.00
pineal gland, adult, donor10258	10377-105G8	90.93	16.93	20.07	6.90	2.51	3.14	0.00
pituitary gland - adult, donor10196	10180-103C9	103.20	53.63	21.25	12.14	4.05	5.06	0.00
pituitary gland, adult, donor10252	10162-103A9	233.49	79.22	18.24	3.65	6.25	4.69	0.00
pituitary gland, adult, donor10258	10378-105G9	74.91	39.16	24.69	16.17	7.66	7.66	1.70
placenta, adult, pool1	10021-101D3	62.89	18.81	1.83	1.18	4.09	0.43	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	19.07	5.56	2.91	1.85	0.13	0.26	0.66
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	19.14	7.16	1.25	0.78	0.16	0.16	0.00
pons, adult, pool1	10033-101E6	16.70	10.67	0.77	0.69	1.72	0.09	0.09
postcentral gyrus, adult, pool1	10032-101E5	17.96	9.15	0.70	0.26	1.83	0.35	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	106.66	108.75	0.00	0.00	2.09	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	5.51	11.02	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	11.74	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	23.45	5.39	2.91	1.46	0.15	0.44	0.44
prostate cancer cell line:PC-3	10439-106E7	23.05	5.99	0.91	0.91	0.18	0.36	0.18
prostate, adult, pool1	10022-101D4	32.29	14.60	1.72	1.63	2.00	0.27	0.09
putamen, adult, donor10196	10176-103C5	18.89	10.62	3.54	1.42	0.94	0.71	0.00
putamen, adult, donor10252	10152-102I8	13.73	5.88	1.96	0.00	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	10.93	5.46	2.19	2.19	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	19.09	7.97	0.97	1.69	0.72	0.97	0.24
putamen, newborn, donor10223	10365-105F5	7.50	2.25	6.00	3.75	0.75	3.00	1.50
rectal cancer cell line:TT1TKB	10469-106I1	29.38	22.69	1.75	0.58	0.29	0.00	0.29
rectum, fetal, donor1	10067-101I4	37.56	13.91	0.00	1.39	6.95	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	31.59	9.75	2.12	0.85	0.21	0.64	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	11.18	4.14	1.24	1.24	0.00	0.41	1.24
retina, adult, pool1	10030-101E3	79.72	32.80	4.67	2.29	4.47	1.99	0.40
retinoblastoma cell line:Y79	10475-106I7	37.15	11.69	2.86	1.82	0.00	0.78	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	22.99	12.54	0.49	1.11	0.12	0.61	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	69.46	41.06	3.37	1.97	0.28	1.12	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	29.56	9.85	0.00	0.00	0.00	0.76	0.00
salivary acinar cells, donor1	11771-123I7	18.13	6.47	3.88	1.62	0.00	0.16	0.16
salivary acinar cells, donor2	11772-123I8	22.17	9.23	3.44	2.07	0.28	0.41	0.14
salivary acinar cells, donor3	11773-123I9	25.82	23.17	1.32	1.99	0.66	0.00	0.00
salivary gland, adult, pool1	10093-102C3	54.91	15.44	1.72	3.43	3.43	1.14	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	27.32	9.86	1.01	1.18	0.00	0.42	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	24.80	6.35	1.41	1.06	0.12	0.24	0.00
seminal vesicle, adult	10201-103F3	74.60	23.28	10.58	10.58	4.23	3.17	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	23.56	10.45	3.89	2.67	1.21	1.46	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	17.87	3.02	0.75	1.01	0.00	0.50	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	15.05	4.01	5.02	0.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	43.52	21.22	4.57	3.90	0.00	1.07	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	35.37	19.23	1.66	1.55	0.00	0.77	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	41.42	8.90	1.55	1.81	0.26	0.52	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	34.76	4.97	0.71	1.42	0.71	2.13	0.00
skeletal muscle, adult, pool1	10023-101D5	42.70	14.03	0.96	0.96	1.68	0.12	0.00
skeletal muscle, fetal, donor1	10066-101I3	12.06	11.06	4.02	1.01	1.01	1.01	0.00
skin, adult, donor1	10074-102A2	33.93	6.79	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	15.15	13.26	0.63	3.79	3.16	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	42.02	17.34	1.67	0.33	2.00	0.67	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	38.77	21.12	11.03	6.62	0.95	4.73	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	35.85	14.46	5.98	2.31	0.58	0.77	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	67.91	19.45	2.47	0.99	0.33	0.99	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	57.75	28.63	6.92	4.66	0.80	1.29	0.97
small cell lung carcinoma cell line:WA-hT	10562-108A4	73.22	18.09	4.79	2.83	1.09	1.09	0.44
small intestine, adult, pool1	10024-101D6	55.90	11.71	3.11	1.67	8.24	0.48	0.12
small intestine, fetal, donor1	10064-101I1	29.97	10.32	7.86	2.95	1.23	2.46	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	36.93	15.90	11.80	5.13	2.56	3.59	1.03
smooth muscle, adult, pool1	10048-101G3	24.29	7.24	3.62	1.29	1.81	0.78	0.26
somatostatinoma cell line:QGP-1	10781-110G7	50.12	33.23	1.88	0.54	0.27	0.27	0.00
spinal cord - adult, donor10196	10181-103D1	11.47	11.24	5.96	2.52	1.38	0.69	0.46
spinal cord, adult, donor10252	10159-103A6	35.88	23.66	2.37	0.39	0.79	0.79	0.39
spinal cord, adult, donor10258	10369-105F9	4.15	6.92	1.38	2.08	4.84	0.69	2.08
spinal cord, fetal, donor1	10056-101H2	23.17	17.08	4.27	2.44	1.22	1.22	0.00
spinal cord, newborn, donor10223	10359-105E8	10.56	7.81	7.81	2.76	0.46	0.92	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	11.65	6.72	0.60	0.00	0.00	0.00	0.00
spleen, adult, pool1	10025-101D7	24.12	15.86	1.10	0.99	0.66	0.22	0.11
spleen, fetal, pool1	10044-101F8	39.17	25.27	2.15	1.99	1.91	0.72	0.40
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	12.73	5.90	0.93	0.62	0.10	0.52	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	29.24	18.42	1.52	1.33	0.00	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	35.99	32.85	26.91	9.44	1.75	5.94	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	19.16	11.34	3.52	1.17	0.00	1.17	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	30.62	12.94	1.01	1.01	0.34	0.34	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	23.30	6.35	4.24	2.12	0.85	1.27	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	14.38	7.62	1.27	1.27	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	39.52	20.29	2.14	4.27	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	41.59	13.10	2.85	5.13	6.84	0.57	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	54.27	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	29.91	25.13	5.82	2.70	2.49	0.83	2.28
substantia nigra, adult, donor10258	10371-105G2	13.45	6.21	0.00	0.52	1.03	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	9.89	12.01	3.53	2.83	1.41	0.00	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	22.47	15.82	1.15	2.06	0.92	0.46	0.00
temporal lobe, adult, pool1	10031-101E4	19.75	9.49	0.76	0.68	1.44	0.08	0.34
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	24.22	7.12	4.27	1.42	0.71	0.00	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	18.02	5.71	2.20	1.76	1.76	1.32	0.00
tenocyte, donor1	11763-123H8	13.96	3.14	5.59	1.75	0.00	1.75	0.00
tenocyte, donor2	11765-123I1	15.64	6.49	3.05	2.29	0.00	0.76	0.00
tenocyte, donor3	11768-123I4	10.01	7.41	3.71	0.74	0.74	1.48	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	14.96	4.08	2.21	0.51	0.00	0.85	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	27.90	15.57	4.78	1.54	0.46	0.77	0.15
teratocarcinoma cell line:PA-1	10807-111A6	11.62	6.66	0.93	0.46	0.46	0.15	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	23.74	26.15	1.65	1.65	0.38	0.51	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	34.04	39.33	6.43	4.16	0.38	2.27	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	26.94	30.21	4.69	3.16	0.87	0.44	1.09
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	14.33	12.38	8.47	6.51	0.33	2.61	0.00
testis, adult, pool1	10026-101D8	38.44	17.50	4.40	3.76	1.83	0.64	3.01
testis, adult, pool2	10096-102C6	70.82	33.38	28.42	6.32	4.06	4.96	12.63
thalamus - adult, donor10196	10168-103B6	8.83	9.94	4.42	1.10	1.10	0.00	1.10
thalamus, adult, donor10252	10154-103A1	36.26	22.66	7.03	3.28	5.63	1.09	1.09
thalamus, adult, donor10258, tech_rep1	10370-105G1	10.78	3.08	1.54	0.00	0.00	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	9.22	5.93	2.96	1.48	0.66	0.33	0.82
thalamus, newborn, donor10223	10366-105F6	2.88	1.73	1.73	0.00	0.00	0.00	0.58
throat, adult	10209-103G2	40.95	14.73	3.25	3.50	3.00	1.50	0.50
throat, fetal, donor1	10061-101H7	35.04	23.77	6.70	4.27	3.96	2.44	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	25.64	16.10	3.78	2.19	0.99	0.00	0.79
thymus, adult, pool1	10027-101D9	30.52	12.73	1.89	1.39	1.39	0.50	0.70
thymus, fetal, pool1	10043-101F7	70.86	30.34	3.01	2.18	3.43	0.62	1.45
thyroid carcinoma cell line:KHM-5M	10776-110G2	14.49	3.06	3.19	1.20	0.00	0.53	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	15.23	11.59	0.98	1.12	0.14	0.28	0.14
thyroid, adult, pool1	10028-101E1	50.58	16.98	3.55	1.87	1.03	0.56	0.56
thyroid, fetal, donor1	10060-101H6	63.02	29.53	9.49	6.59	3.43	1.32	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	89.31	15.40	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	24.65	7.44	8.37	3.95	0.93	0.70	0.00
tongue, fetal, donor1	10059-101H5	20.10	6.31	5.12	3.55	2.76	0.39	0.00
tonsil, adult, pool1	10047-101G2	50.29	18.53	1.70	1.80	2.40	0.60	0.10
trachea, adult, pool1	10029-101E2	40.57	19.30	2.62	1.72	1.06	1.23	0.08
trachea, fetal, donor1	10058-101H4	21.16	8.46	3.46	2.31	0.77	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	12.05	4.61	0.71	0.71	0.00	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	25.03	9.42	1.52	1.52	0.00	0.20	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	21.15	14.73	2.51	2.35	0.16	0.47	0.78
tridermal teratoma cell line:HGRT	10694-109G1	19.03	17.12	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	77.96	52.99	5.25	2.12	0.08	2.03	0.08
umbilical cord, fetal, donor1	10057-101H3	25.04	14.61	6.26	4.17	2.09	2.09	0.00
uterus, adult, pool1	10100-102D1	54.26	26.11	4.61	1.71	1.54	1.71	0.00
uterus, fetal, donor1	10055-101H1	21.50	12.80	2.05	2.56	0.51	1.02	0.00
vagina, adult	10204-103F6	41.36	5.82	0.65	1.29	0.65	0.00	0.00
vein, adult	10191-103E2	35.29	14.03	7.89	3.51	2.19	0.88	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	12.82	4.01	1.60	0.80	0.27	0.27	0.27